© 2000-2019 QIAGEN. All rights reserved.

Analysis Details for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Workspace	My Projects
Project	hdMouse_Microarray_Final
Analysis	R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Date	Mon Oct 21 06:57:53 PDT 2019
Analysis ID	18427485

Analysis Settings
Cutoff before duplicate resolution	true
Resolve duplicate on	Expression logfoldchange
Color using	Expression logfoldchange
Cutoff for Expression logfoldchange	--
Cutoff for Expression pvalue	--
Reference set	Mouse Genome 430 2.0 Array
Relationship to include	Direct and Indirect
Includes Endogenous Chemicals	Yes
Optional Analyses	My Pathways My List
Filter Summary	
Consider only molecules and/or relationships where
(confidence = Experimentally Observed) AND
(mol. types = biologic drug OR canonical pathway OR chemical - endogenous mammalian OR chemical - endogenous non-mammalian OR chemical - kinase inhibitor OR chemical - other OR chemical - protease inhibitor OR chemical drug OR chemical reagent OR chemical toxicant OR complex OR cytokine OR disease OR enzyme OR function OR G-protein coupled receptor OR group OR growth factor OR ion channel OR kinase OR ligand-dependent nuclear receptor OR mature microRNA OR microRNA OR other OR peptidase OR phosphatase OR transcription regulator OR translation regulator OR transmembrane receptor OR transporter)

Canonical Pathways for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Ingenuity Canonical Pathways	 -log(p-value)	zScore	Ratio	Molecules
Glucocorticoid Receptor Signaling	2.57E-01		3.27E-03	STAT1	
Protein Ubiquitination Pathway	3.1E-01		3.91E-03	USP18	
Colorectal Cancer Metastasis Signaling	3.32E-01		4.18E-03	STAT1	
EIF2 Signaling	4.03E-01		5.21E-03	EIF2AK2	
Gap Junction Signaling	4.12E-01		5.35E-03	TJP2	
ERK/MAPK Signaling	4.21E-01		5.49E-03	STAT1	
PPARα/RXRα Activation	4.29E-01		5.62E-03	HELZ2	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	4.34E-01		5.71E-03	STAT1	
Sertoli Cell-Sertoli Cell Junction Signaling	4.38E-01		5.78E-03	TJP2	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	4.42E-01		5.85E-03	STAT1	
Hepatic Cholestasis	4.44E-01		5.88E-03	TJP2	
NF-κB Signaling	4.51E-01		5.99E-03	EIF2AK2	
Tight Junction Signaling	4.72E-01		6.37E-03	TJP2	
Th1 and Th2 Activation Pathway	4.98E-01		6.85E-03	STAT1	
Granulocyte Adhesion and Diapedesis	5.01E-01		6.90E-03	SDC3	
IL-15 Production	5.89E-01		8.77E-03	STAT1	
Renin-Angiotensin Signaling	5.89E-01		8.77E-03	STAT1	
p38 MAPK Signaling	5.99E-01		9.01E-03	STAT1	
Pancreatic Adenocarcinoma Signaling	6.2E-01		9.52E-03	STAT1	
Th1 Pathway	6.38E-01		1.00E-02	STAT1	
Type I Diabetes Mellitus Signaling	6.46E-01		1.02E-02	STAT1	
TGF-β Signaling	6.62E-01		1.06E-02	IRF7	
HIPPO signaling	7.15E-01		1.22E-02	TJP2	
NF-κB Activation by Viruses	7.2E-01		1.23E-02	EIF2AK2	
Role of BRCA1 in DNA Damage Response	7.24E-01		1.25E-02	STAT1	
Prolactin Signaling	7.29E-01		1.27E-02	STAT1	
IL-3 Signaling	7.39E-01		1.30E-02	STAT1	
IL-7 Signaling Pathway	7.66E-01		1.39E-02	STAT1	
Toll-like Receptor Signaling	7.77E-01		1.43E-02	EIF2AK2	
GM-CSF Signaling	7.83E-01		1.45E-02	STAT1	
Growth Hormone Signaling	7.94E-01		1.49E-02	STAT1	
Role of JAK1 and JAK3 in γc Cytokine Signaling	7.94E-01		1.49E-02	STAT1	
Pyridoxal 5'-phosphate Salvage Pathway	8.13E-01		1.56E-02	EIF2AK2	
TREM1 Signaling	8.13E-01		1.56E-02	NLRC5	
T Helper Cell Differentiation	8.19E-01		1.59E-02	STAT1	
Neuroinflammation Signaling Pathway	8.23E-01		7.58E-03	IRF7,STAT1	
Thrombopoietin Signaling	8.25E-01		1.61E-02	STAT1	
CNTF Signaling	8.74E-01		1.82E-02	STAT1	
EGF Signaling	8.81E-01		1.85E-02	STAT1	
iNOS Signaling	9.65E-01		2.27E-02	STAT1	
Oncostatin M Signaling	9.84E-01		2.38E-02	STAT1	
Pyrimidine Ribonucleotides De Novo Biosynthesis	1E00		2.50E-02	CMPK2	
Pyrimidine Ribonucleotides Interconversion	1.03E00		2.63E-02	CMPK2	
IL-9 Signaling	1.1E00		3.12E-02	STAT1	
Role of JAK2 in Hormone-like Cytokine Signaling	1.11E00		3.23E-02	STAT1	
Antigen Presentation Pathway	1.17E00		3.70E-02	NLRC5	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.2E00		4.00E-02	STAT1	
IL-22 Signaling	1.22E00		4.17E-02	STAT1	
Tec Kinase Signaling	1.23E00		1.32E-02	STAT1,STAT2	
Dendritic Cell Maturation	1.24E00		1.33E-02	STAT1,STAT2	
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	1.27E00		4.76E-02	CMPK2	
IL-12 Signaling and Production in Macrophages	1.47E00		1.80E-02	JMJD6,STAT1	
Salvage Pathways of Pyrimidine Ribonucleotides	1.65E00		2.25E-02	CMPK2,EIF2AK2	
Death Receptor Signaling	1.68E00		2.33E-02	PARP12,PARP14	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	1.69E00		1.25E-01	RSAD2	
PDGF Signaling	1.69E00		2.35E-02	EIF2AK2,STAT1	
JAK/Stat Signaling	1.75E00		2.53E-02	STAT1,STAT2	
FLT3 Signaling in Hematopoietic Progenitor Cells	1.76E00		2.56E-02	STAT1,STAT2	
T Cell Exhaustion Signaling Pathway	2.27E00		2.19E-02	IRF9,STAT1,STAT2	
Retinoic acid Mediated Apoptosis Signaling	2.31E00		5.00E-02	PARP12,PARP14	
Role of PKR in Interferon Induction and Antiviral Response	2.31E00		5.00E-02	EIF2AK2,STAT1	
UVA-Induced MAPK Signaling	2.73E00		3.19E-02	PARP12,PARP14,STAT1	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	2.87E00		9.52E-02	STAT1,STAT2	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	3.4E00		2.99E-02	DDX58,EIF2AK2,IRF7,OAS2	
Systemic Lupus Erythematosus In B Cell Signaling Pathway	3.44E00	2.23606797749979	2.10E-02	IFIT2,IRF7,IRF9,STAT1,STAT2	
Role of RIG1-like Receptors in Antiviral Innate Immunity	4.15E00		9.68E-02	DDX58,DHX58,IRF7	
Interferon Signaling	6.05E00		1.38E-01	IFI35,IRF9,STAT1,STAT2	
Activation of IRF by Cytosolic Pattern Recognition Receptors	1.23E01	2.1213203435596424	1.60E-01	DDX58,DHX58,IFIT2,IRF7,IRF9,STAT1,STAT2,ZBP1	

Upstream Regulators for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Analysis	ID	Upstream Regulator	Expr Log Ratio	Molecule Type	Predicted Activation State	Activation z-score	Notes	Bias Term	Bias-corrected z-score	p-value of overlap	Target molecules in dataset	Mechanistic Network	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF7	1.812	transcription regulator	Activated	4.891	bias	0.636	 	1.64E-42	CMPK2,DDX58,DHX58,HELZ2,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,Mx1,OAS2,OASL,Oasl2,PARP12,PARP14,RSAD2,RTP4,STAT1,STAT2,Trim30a/Trim30d,USP18,XAF1,ZBP1	IFNB1,IL1B,IRF3,IRF7,IRF9,Interferon alpha,SIRT1,SPI1,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PNPT1	 	enzyme	Inhibited	-4.333	bias	-0.518	 	5.54E-39	CMPK2,DDX58,EIF2AK2,IFI16,IFIT1B,IRF7,Irgm1,LGALS3BP,Oasl2,PARP12,PARP14,RNF213,RTP4,Sp100,STAT1,STAT2,Trim30a/Trim30d,USP18,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF3	 	transcription regulator	Activated	4.785	bias	0.490	2.443	4.16E-38	CMPK2,DDX58,DHX58,EIF2AK2,HELZ2,IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,IRF7,Irgm1,Mx1,NLRC5,OAS2,OASL,Oasl2,PARP12,PARP14,RSAD2,STAT1,STAT2,Trim30a/Trim30d,USP18,ZBP1	IFN type 1,IFNA1/IFNA13,IFNB1,IL1B,IRF3,IRF7,SIRT1,SPI1,STAT2,STAT3,STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Ifnar	 	group	Activated	4.488	bias	0.592	 	1.63E-37	DDX58,EIF2AK2,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,Mx1,NLRC5,OAS2,OASL,RNF213,RSAD2,Sp100,STAT1,STAT2,USP18,XAF1,ZBP1	IFNB1,IFNG,IRF1,IRF3,IRF5,IRF7,IRF9,Ifnar,STAT1,STAT2,STAT3,poly rI:rC-RNA	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNB1	 	cytokine	Activated	4.040	 	0.233	3.098	2.91E-31	CMPK2,DDX58,DHX58,EIF2AK2,IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,Mx1,OAS2,Oasl2,PARP12,PARP14,RSAD2,STAT1,STAT2,Trim30a/Trim30d,USP18,XAF1,ZBP1	IFNAR1,IFNB1,IRF3,IRF7,IRF9,Interferon alpha,JAK1,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	STAT1	0.706	transcription regulator	Activated	4.406	bias	0.439	2.472	1.12E-30	CMPK2,EIF2AK2,HERC6,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,Mx1,NLRC5,OAS2,OASL,Oasl2,RNF213,RSAD2,RTP4,SLFN5,STAT1,STAT2,USP18,XAF1,ZBP1	IFNG,IRF1,IRF9,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ACKR2	 	g-protein coupled receptor	Inhibited	-3.873	bias	-0.574	 	1.07E-29	DDX58,DHX58,EIF2AK2,IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,IRF7,OAS2,OASL,Oasl2,RSAD2,STAT1,STAT2,USP18	ACKR2,Immunoglobulin,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM24	 	transcription regulator	Inhibited	-4.186	bias	-0.591	 	1.60E-29	CMPK2,DDX58,DHX58,HERC6,Ifi27l2a/Ifi27l2b,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,LGALS3BP,OASL,PARP12,RTP4,STAT1,STAT2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNL1	 	cytokine	Activated	3.960	bias	0.589	 	1.69E-29	CMPK2,DDX58,EIF2AK2,HERC6,IFI35,IFIT2,IRF9,LGALS3BP,OAS2,OASL,RSAD2,RTP4,STAT1,STAT2,USP18,XAF1	IFNL1,IRF9,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Interferon alpha	 	group	Activated	4.307	bias	0.415	2.519	2.36E-29	DDX58,DHX58,EIF2AK2,HELZ2,HERC6,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Mx1,OAS2,Oasl2,PARP12,PARP14,RNF213,RSAD2,RTP4,SLFN5,STAT1,STAT2,USP18,ZBP1	IFNB1,IRF3,IRF7,IRF9,Interferon alpha,JAK1,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFN Beta	 	group	Activated	4.022	bias	0.483	2.082	3.11E-27	DDX58,EIF2AK2,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Mx1,OAS2,OASL,RSAD2,STAT1,STAT2,USP18,XAF1,ZBP1	IFN Beta,IRF1,IRF7,IRF9,Ifnar,MAPK1,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNAR1	 	transmembrane receptor	Activated	3.257	bias	0.403	1.944	1.34E-25	CMPK2,EIF2AK2,IFI16,IFIT1B,IFIT2,IRF7,Mx1,OAS2,OASL,Oasl2,PARP12,RSAD2,RTP4,Sp100,STAT1,USP18,XAF1	IFNAR1,IFNB1,IL1B,IRF3,IRF9,MYC,SIRT1,SPI1,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PTGER4	 	g-protein coupled receptor	Inhibited	-4.088	 	-0.139	-3.521	1.06E-24	CMPK2,DDX58,HERC6,IFI16,IFI35,IFIT1B,IFIT2,IRF7,Irgm1,Mx1,PARP14,RNF213,RSAD2,RTP4,SLFN5,USP18,XAF1	IFNG,IRF1,MYC,PTGER4,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	STAT2	0.577	transcription regulator	Activated	2.374	bias	0.371	1.493	6.78E-24	IFI35,IFIT1B,IFIT2,IRF7,IRF9,Mx1,OAS2,Oasl2,RSAD2,RTP4,STAT1,USP18,ZBP1	IFNAR1,IRF9,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAVS	 	other	Activated	3.563	bias	0.582	 	2.28E-23	CMPK2,DDX58,DHX58,IFIT1B,IFIT2,IRF7,OAS2,OASL,Oasl2,PARP12,RSAD2,STAT1,STAT2	DDX58,IFNB1,IRF3,IRF5,IRF7,MAVS,STAT1,STAT3,TBK1	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA2	 	cytokine	Activated	4.043	bias	0.521	 	2.49E-22	CMPK2,DDX58,EIF2AK2,HERC6,IFI16,IFI35,IFIT2,IRF7,IRF9,LGALS3BP,OAS2,PARP12,RSAD2,STAT1,USP18,XAF1,ZBP1	IFNA2,MAPK1,MYC,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	poly rI:rC-RNA	 	biologic drug	Activated	4.396	bias	0.457	2.387	6.52E-21	DDX58,DHX58,EIF2AK2,IFI16,IFIT1B,IFIT2,IRF7,IRF9,Mx1,NLRC5,OAS2,OASL,Oasl2,PARP14,RSAD2,Sp100,STAT1,STAT2,Trim30a/Trim30d,ZBP1	IFN Beta,IFN type 1,IFNB1,IRF1,IRF3,IRF7,MAVS,STAT1,STAT2,STAT3,STAT4,poly rI:rC-RNA	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SIRT1	 	transcription regulator	Inhibited	-4.359	bias	-0.268	-3.192	2.06E-20	CMPK2,DDX58,DHX58,HELZ2,IFIT1B,IRF7,Irgm1,LGALS3BP,NLRC5,OAS2,Oasl2,PARP12,PARP14,RNF213,RSAD2,RTP4,STAT1,Trim30a/Trim30d,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RNASEH2A	 	enzyme	 	 	 	 	 	2.86E-20	DDX58,IFI16,Ifi27l2a/Ifi27l2b,IFI35,IFIT1B,IFIT2,IRF7,IRF9,OASL,RSAD2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PRL	 	cytokine	Activated	4.123	bias	0.415	2.413	4.87E-20	CMPK2,DDX58,DHX58,EIF2AK2,HELZ2,HERC6,IFI35,IRF7,IRF9,OAS2,PARP12,PARP14,RSAD2,STAT1,STAT2,USP18,XAF1	IRF1,IRF7,MAPK1,PRL,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF5	 	transcription regulator	Activated	3.397	bias	0.441	1.900	2.09E-19	CMPK2,DDX58,DHX58,IFIT2,IRF7,OAS2,OASL,Oasl2,PARP12,RSAD2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DNASE2	 	enzyme	 	-1.982	bias	-0.636	 	2.69E-19	DHX58,IFIT1B,IRF7,Mx1,Oasl2,RSAD2,RTP4,Sp100,USP18,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF1	 	transcription regulator	Activated	3.516	bias	0.455	1.918	1.37E-18	CMPK2,DDX58,EIF2AK2,HELZ2,IFI35,IFIT2,IRF7,IRF9,OAS2,OASL,RSAD2,STAT1,STAT2,XAF1	IFN Beta,IFNG,IRF1,IRF3,IRF7,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFN type 1	 	group	Activated	3.109	bias	0.405	1.850	3.80E-18	DDX58,DHX58,EIF2AK2,IFI16,IFIT1B,IFIT2,Mx1,OASL,STAT1,STAT2	IFN type 1,STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA1/IFNA13	 	cytokine	Activated	3.087	bias	0.382	1.908	5.05E-18	DHX58,EIF2AK2,IFIT2,IRF7,Mx1,OAS2,RSAD2,STAT1,STAT2,ZBP1	IFNA1/IFNA13,IRF9,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	STAT3	 	transcription regulator	Inhibited	-2.863	bias	0.308	-4.127	5.84E-18	CMPK2,EIF2AK2,HERC6,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,Mx1,OAS2,OASL,RSAD2,SLFN5,STAT1,STAT2,USP18,XAF1	IFNAR1,IFNG,IL1B,IRF1,IRF3,IRF9,MYC,SIRT1,SPI1,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL21	 	cytokine	Activated	3.606	bias	0.455	1.967	4.69E-17	CMPK2,EIF2AK2,HERC6,IFI16,IFIT1B,IFIT2,IRF7,Irgm1,OAS2,OASL,RSAD2,STAT2,USP18	IFNG,IL21,IRF1,IRF9,Immunoglobulin,MYC,MYD88,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNG	 	cytokine	Activated	4.706	bias	0.257	3.495	8.92E-17	CMPK2,DDX58,EIF2AK2,HERC6,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,LGALS3BP,Mx1,NLRC5,OAS2,OASL,PARP14,RSAD2,RTP4,SLFN5,STAT1,STAT2,USP18,XAF1	IFNG,IL21,IRF1,IRF7,IRF9,MAPK1,MYC,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DDX58	0.602	enzyme	Activated	2.297	bias	0.566	 	1.69E-16	DDX58,EIF2AK2,IFI35,IFIT1B,IFIT2,IRF7,Mx1,RSAD2,STAT1,STAT2	DDX58,IFN type 1,IRF3,IRF7,IRF9,Interferon alpha,MAVS,MYC,STAT1,STAT2,STAT3,STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Ifn	 	group	Activated	3.249	bias	0.450	1.788	3.63E-16	DDX58,DHX58,EIF2AK2,IFI16,IRF7,Mx1,OAS2,OASL,RSAD2,STAT1,ZBP1	Ifn,Ifnar,STAT1	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NKX2-3	 	transcription regulator	Inhibited	-3.606	 	0.027	-3.704	1.26E-15	CMPK2,DDX58,DHX58,EIF2AK2,HELZ2,PARP12,PARP14,RNF213,RTP4,STAT1,STAT2,USP18,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TLR9	 	transmembrane receptor	Activated	3.406	bias	0.494	1.723	1.26E-15	IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Mx1,OAS2,Oasl2,RSAD2,STAT1,STAT2,USP18	IFNB1,IRF1,IRF3,IRF7,IRF9,Interferon alpha,MYC,STAT1,STAT2,STAT3,TLR7,TLR9	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Irgm1	0.600	other	Inhibited	-3.000	bias	-0.636	 	1.56E-15	IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,IRF7,OAS2,OASL,RSAD2,USP18	IL1B,IRF3,Irgm1,SIRT1,SPI1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TLR3	 	transmembrane receptor	Activated	2.778	bias	0.579	 	2.34E-15	CMPK2,DDX58,DHX58,EIF2AK2,IFI16,IFIT2,IRF7,Mx1,OASL,Oasl2,RSAD2,STAT1,USP18	IFN type 1,IFNB1,IRF3,IRF5,IRF7,STAT3,STAT4,TICAM1,TLR3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFN alpha/beta	 	group	Activated	3.120	bias	0.495	1.576	3.48E-15	IFI16,Ifi27l2a/Ifi27l2b,IFIT2,IRF7,Irgm1,Mx1,RSAD2,Sp100,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SOCS1	 	other	Inhibited	-3.119	bias	-0.514	 	6.29E-15	DDX58,IFI16,IFIT1B,IFIT2,IRF7,Mx1,OAS2,Oasl2,RSAD2,STAT1,USP18	IFNB1,IRF3,IRF7,IRF9,MYC,SOCS1,STAT1,STAT2,STAT3,STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ribavirin	 	chemical drug	Activated	2.828	bias	0.354	1.828	7.57E-15	DDX58,EIF2AK2,IFIT2,IRF7,OASL,RSAD2,STAT1,USP18	IFNG,IRF1,STAT1,STAT3,ribavirin	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	FADD	 	other	Activated	3.118	bias	0.297	2.192	1.34E-14	DDX58,DHX58,EIF2AK2,IFIT1B,IFIT2,IRF7,Mx1,Sp100,STAT1,STAT2	FADD,IRF3,IRF7,MAVS	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	STAT6	 	transcription regulator	Inhibited	-2.949	 	0.070	-3.218	3.60E-14	CMPK2,DHX58,EIF2AK2,IFI16,IFIT1B,IRF7,IRF9,Irgm1,LGALS3BP,Mx1,OASL,RNF213,STAT2,Trim30a/Trim30d,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL1RN	 	cytokine	Inhibited	-3.162	bias	-0.470	-1.675	4.36E-14	DDX58,HERC6,IRF7,IRF9,OAS2,OASL,RSAD2,RTP4,STAT2,USP18	IFNG,IFNL1,IL1RN,IRF1,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF9	0.754	transcription regulator	 	1.987	 	0.076	1.835	4.92E-14	IFIT2,IRF7,OAS2,Oasl2,RTP4,STAT1,STAT2,ZBP1	IRF7,IRF9,Interferon alpha,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAPK1	 	kinase	Inhibited	-3.719	 	0.034	-3.845	5.09E-14	DDX58,EIF2AK2,IFI16,IFI35,IFIT2,IRF7,IRF9,LGALS3BP,OAS2,OASL,PARP12,STAT1,STAT2,USP18	IRF1,MAPK1,MYC,PRL,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	APP	 	other	Activated	4.088	 	0.208	3.238	5.34E-14	CMPK2,DDX58,HERC6,HPCA,IFI16,IFI35,IFIT1B,IFIT2,IRF7,Irgm1,Mx1,Nrgn,PARP14,RNF213,RSAD2,RTP4,SLFN5,USP18,XAF1	APP,MYC,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TREX1	 	enzyme	Inhibited	-2.388	bias	-0.521	 	1.18E-13	IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,OASL,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TMEM173	 	other	Activated	2.586	bias	0.636	 	1.21E-13	IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IRF7,Mx1,OASL,RSAD2,USP18	IRF3,IRF5,IRF7,STAT1,TBK1,TMEM173	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	lipopolysaccharide	 	chemical drug	Activated	4.821	bias	0.287	3.439	1.36E-13	CMPK2,DDX58,DHX58,EIF2AK2,IFI16,IFI35,IFIT1B,IFIT2,IRF7,IRF9,Irgm1,LGALS3BP,Mx1,NLRC5,OAS2,OASL,PARP12,PARP14,RSAD2,STAT1,STAT2,Trim30a/Trim30d,USP18,XAF1	IFN Beta,IFNB1,IFNG,IRF1,IRF3,IRF7,MAPK1,STAT1,STAT2,STAT3,lipopolysaccharide	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CNOT7	 	transcription regulator	 	 	 	 	 	1.42E-13	CMPK2,HERC6,IFI35,LGALS3BP,OAS2,PARP12,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SASH1	 	other	Activated	3.000	bias	0.636	 	1.71E-13	CMPK2,HELZ2,IFIT1B,IFIT2,IRF7,OASL,RSAD2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CGAS	 	enzyme	Activated	2.412	bias	0.636	 	2.36E-13	IFIT1B,IFIT2,IRF7,Mx1,RSAD2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TICAM1	 	other	Activated	3.109	bias	0.603	 	5.95E-13	CMPK2,DDX58,IFI16,IFIT1B,IFIT2,IRF7,Irgm1,Mx1,OASL,RSAD2	IRF3,IRF5,IRF7,MYC,MYD88,NFATC2,SPI1,STAT1,STAT3,TBK1,TICAM1,TLR4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TBK1	 	kinase	 	0.399	bias	0.310	-0.392	5.99E-13	CMPK2,IFIT1B,IFIT2,IRF7,Mx1,OAS2,OASL,Oasl2,RSAD2	IRF3,IRF5,IRF7,IRF9,STAT1,STAT2,STAT3,TBK1,TMEM173	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SAMSN1	 	other	Activated	3.000	bias	0.607	 	1.31E-12	CMPK2,HELZ2,IFIT1B,IFIT2,IRF7,OASL,RSAD2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	FZD9	 	g-protein coupled receptor	Activated	2.425	bias	0.636	 	2.03E-12	IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IRF7,Oasl2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	JAK1	 	kinase	Activated	2.236	bias	0.566	 	2.35E-12	EIF2AK2,IFIT2,IRF7,IRF9,Oasl2,STAT1,STAT2,USP18	IRF9,JAK1,MAPK1,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TLR7	 	transmembrane receptor	Activated	2.975	bias	0.611	 	6.20E-12	IFI35,IFIT1B,IRF7,IRF9,Mx1,OAS2,RSAD2,STAT1,STAT2	IFNA1/IFNA13,IRF1,IRF3,IRF7,IRF9,Interferon alpha,MYC,STAT1,STAT2,STAT3,TLR7	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DOCK8	 	other	Activated	2.828	bias	0.636	 	6.92E-12	CMPK2,HELZ2,IFIT1B,IFIT2,IRF7,RSAD2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	oblimersen	 	biologic drug	Activated	2.646	bias	0.576	 	1.51E-11	IFI16,IFI35,IRF7,OAS2,OASL,RSAD2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TLR4	 	transmembrane receptor	Activated	2.571	bias	0.443	1.431	1.95E-11	CMPK2,HELZ2,IFI16,IFIT1B,IFIT2,IRF7,Irgm1,Mx1,OASL,RSAD2,STAT1,STAT2	IRF3,IRF7,MYC,NFATC2,STAT1,STAT3,TICAM1,TLR4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TGM2	 	enzyme	Activated	3.162	bias	0.267	2.319	4.11E-11	IFI35,IFIT2,IRF9,OAS2,OASL,PARP14,RNF213,SLFN5,STAT1,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	E. coli B4 lipopolysaccharide	 	chemical toxicant	Activated	3.248	bias	0.397	1.960	7.80E-11	DDX58,IFI16,IFI35,IFIT1B,Mx1,Oasl2,RSAD2,RTP4,Trim30a/Trim30d,USP18,ZBP1	E. coli B4 lipopolysaccharide,IRF3,IRF7,SOCS1,STAT2,STAT3,STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	mitoxantrone	 	chemical drug	 	 	 	 	 	1.17E-10	IFI16,IFIT2,IRF7,Mx1,OAS2,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CpG ODN 2006	 	chemical reagent	Activated	2.621	bias	0.382	1.620	1.43E-10	IFI35,IFIT2,IRF7,IRF9,OASL,RSAD2,STAT1	CpG ODN 2006,IRF1,IRF7,MYC,MYD88,STAT1,STAT3,TLR9	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAPKAP1	 	other	Activated	2.236	bias	0.545	 	2.14E-10	IFI16,IFIT2,Mx1,OAS2,SLFN5	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SPI1	 	transcription regulator	Activated	2.828	bias	0.280	2.036	2.41E-10	CMPK2,HELZ2,IFIT1B,IFIT2,IRF7,IRF9,OASL,PARP12,RSAD2,USP18	IL1B,IRF3,SIRT1,SPI1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA4	 	cytokine	Activated	2.449	bias	0.636	 	2.72E-10	IFIT2,Irgm1,OASL,RSAD2,USP18,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL4	 	cytokine	Inhibited	-3.450	bias	0.331	-4.666	4.27E-10	CMPK2,DHX58,EIF2AK2,IFI16,IFIT1B,IRF7,IRF9,Irgm1,LGALS3BP,Mx1,OASL,RNF213,STAT1,STAT2,Trim30a/Trim30d,ZBP1	IL4,STAT6	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	tretinoin	 	chemical - endogenous mammalian	Activated	3.652	 	0.223	2.702	5.36E-10	DDX58,DHX58,EIF2AK2,IFI16,IFI35,IFIT2,IRF9,LGALS3BP,Nrgn,OAS2,OASL,PARP14,RNF213,RTP4,SLFN5,STAT1,STAT2,USP18,XAF1	IFNG,IRF1,MAPK1,STAT1,STAT3,tretinoin	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TNK1	 	kinase	Activated	2.236	bias	0.636	 	6.59E-10	IFI16,IFIT1B,IFIT2,IRF7,OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNLR1	 	transmembrane receptor	 	 	 	 	 	9.29E-10	CMPK2,IFIT1B,IFIT2,IRF7,OASL,RSAD2	IFNLR1,MYC,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EIF2AK2	1.021	kinase	Activated	2.611	bias	0.557	 	1.04E-09	DDX58,EIF2AK2,IFI35,LGALS3BP,PARP12,STAT1,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NFATC2	 	transcription regulator	Activated	3.000	bias	0.314	2.058	1.21E-09	CMPK2,HELZ2,IFIT1B,IFIT2,IRF7,OASL,RSAD2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNL4	 	cytokine	Activated	2.000	bias	0.636	 	1.56E-09	DDX58,DHX58,OAS2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNL3	 	cytokine	Activated	2.230	bias	0.636	 	3.54E-09	DDX58,Mx1,RSAD2,STAT1,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNAR2	 	transmembrane receptor	 	 	 	 	 	1.23E-08	DDX58,Mx1,OAS2,USP18,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	JAK1/2	 	group	 	0.128	bias	0.616	 	1.73E-08	CTXN1,EIF2AK2,HPCA,IRF7,Nrgn,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAP3K7	 	kinase	 	0.816	 	0.233	0.245	2.09E-08	DDX58,IFIT2,IRF7,OAS2,OASL,XAF1	IRF5,MAP3K7	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	imiquimod	 	chemical drug	Activated	2.443	bias	0.515	 	3.26E-08	IFI35,IRF7,OASL,RNF213,RSAD2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	JAK	 	group	Activated	2.236	bias	0.467	1.193	5.12E-08	DDX58,EIF2AK2,IFIT2,RSAD2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PARP9	 	enzyme	 	1.980	bias	0.561	 	1.04E-07	IFIT2,IRF7,OAS2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	1,2-dioleoyloxy-3-(trimethylammonium)propane	 	chemical reagent	 	 	 	 	 	1.79E-07	IFIT1B,IRF7,Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ELAVL1	 	other	Activated	2.449	bias	0.439	1.375	2.15E-07	IFI16,IRF9,Irgm1,LGALS3BP,OAS2,STAT1,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IKBKE	 	kinase	 	1.300	bias	0.429	0.345	2.34E-07	IFI16,IFIT2,IRF7,RSAD2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	mir-21	 	microrna	Inhibited	-2.777	bias	-0.446	-1.537	3.20E-07	DHX58,IFI16,Irgm1,NLRC5,OAS2,Sp100,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ISGF3	 	complex	 	 	 	 	 	3.57E-07	IFIT2,IRF7,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	dexamethasone	 	chemical drug	Inhibited	-2.965	 	0.078	-3.243	3.81E-07	CMPK2,DDX58,HELZ2,Ifi27l2a/Ifi27l2b,IFI35,IFIT1B,IFIT2,IRF7,IRF9,LGALS3BP,OASL,PARP14,RSAD2,STAT1,STAT2,Trim30a/Trim30d,USP18,XAF1	IFNG,IRF1,PRL,STAT1,STAT3,dexamethasone	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	salmonella minnesota R595 lipopolysaccharides	 	chemical - endogenous non-mammalian	Activated	2.429	bias	0.636	 	3.83E-07	CMPK2,IFIT1B,IFIT2,OASL,RSAD2,SLFN5	IRF3,IRF7,NFATC2,SPI1,STAT3,TLR4,salmonella minnesota R595 lipopolysaccharides	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNE	 	cytokine	Activated	2.000	bias	0.636	 	8.74E-07	IFIT2,STAT1,USP18,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL10RA	 	transmembrane receptor	Inhibited	-2.828	 	0.039	-2.939	1.05E-06	IFI16,IRF7,Irgm1,NLRC5,RNF213,RSAD2,STAT1,ZBP1	IL10RA,IRF9,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MYD88	 	other	Activated	2.537	bias	0.574	 	1.25E-06	CMPK2,IFIT1B,IFIT2,IRF7,OASL,RSAD2,USP18	IL1B,IRF3,IRF7,MYC,MYD88,NFATC2,SIRT1,SPI1,STAT1,STAT3,TLR4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFIH1	 	enzyme	 	 	 	 	 	1.96E-06	IRF7,Mx1,OAS2,RSAD2	IFIH1,IRF3,IRF5,IRF7,STAT1,TBK1	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PML	 	transcription regulator	Activated	2.425	 	-0.014	2.460	2.11E-06	HERC6,IFI35,IRF7,Mx1,OAS2,STAT1	MYC,PML,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TCR	 	complex	 	 	 	 	 	2.69E-06	ARPP21,DDX58,DHX58,IFIT2,IRF7,OASL,RSAD2,STAT1	IRF5,MAP3K7,NFATC2,TCR	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PAF1	 	other	Activated	2.000	bias	0.636	 	2.77E-06	DDX58,HELZ2,OAS2,OASL	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NSD2	 	enzyme	 	 	 	 	 	3.09E-06	IFIT1B,IRF7,Mx1,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	stallimycin	 	biologic drug	 	1.954	bias	0.603	 	3.09E-06	IFI16,IFIT2,IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	6-aminopyrazolopyrimidine derivative compound II	 	chemical - kinase inhibitor	 	 	 	 	 	3.88E-06	IFIT1B,IRF7,Oasl2	6-aminopyrazolopyrimidine derivative compound II,IRF3,IRF5,IRF7,STAT1,TBK1	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	bromodeoxyuridine	 	chemical drug	 	1.954	bias	0.608	 	6.16E-06	IFI16,IFIT2,IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNK	 	cytokine	 	 	 	 	 	6.39E-06	EIF2AK2,STAT1,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	pegintron	 	biologic drug	 	 	 	 	 	7.01E-06	DDX58,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	phosphatidylethanolamine	 	chemical - endogenous mammalian	 	 	 	 	 	7.01E-06	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	poly dA-dT	 	chemical reagent	 	 	 	 	 	7.98E-06	RSAD2,STAT1,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NRAS	 	enzyme	Inhibited	-2.425	bias	-0.250	-1.818	8.47E-06	IFI16,IFI35,IFIT1B,Irgm1,STAT1,USP18	MYC,NRAS,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IKZF3	 	transcription regulator	Inhibited	-2.000	bias	-0.537	 	1.19E-05	DDX58,IRF7,RNF213,RTP4	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF8	 	transcription regulator	 	 	 	 	 	1.35E-05	DDX58,IFIT1B,IFIT2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CpG ODN 2216	 	chemical reagent	 	 	 	 	 	1.42E-05	IFIT1B,IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	STAT4	 	transcription regulator	Activated	2.449	bias	0.636	 	2.30E-05	DDX58,IFIT1B,IFIT2,Mx1,STAT1,Trim30a/Trim30d	DDX58,STAT3,STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFI16	2.363	transcription regulator	 	1.969	bias	0.558	 	3.22E-05	DDX58,IFI16,Mx1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	FCER1G	 	transmembrane receptor	 	 	 	 	 	3.49E-05	IFIT2,Mx1,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	VCAN	 	other	Activated	2.219	 	0.050	2.109	3.85E-05	IFIT2,OAS2,PARP14,STAT1,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CC-122	 	chemical drug	 	 	 	 	 	4.19E-05	DDX58,IRF7	CC-122,IKZF3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	poly(dG-dC)	 	chemical reagent	 	 	 	 	 	4.19E-05	RSAD2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	GAPDH	 	enzyme	 	 	 	 	 	5.01E-05	IFIT2,OAS2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TNFSF10	 	cytokine	Activated	2.000	 	0.086	1.828	5.25E-05	EIF2AK2,IFI16,IRF9,STAT1	MAPK1,STAT3,TNFSF10	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	filgrastim	 	biologic drug	Inhibited	-2.626	 	-0.110	-2.337	5.65E-05	DDX58,IFIT2,OASL,PARP14,RSAD2,STAT1,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	aldesleukin	 	biologic drug	 	 	 	 	 	6.92E-05	IFI35,IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	pristane	 	chemical toxicant	 	 	 	 	 	7.65E-05	IFI16,IRF7,Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ZNF395	 	other	 	 	 	 	 	1.04E-04	IFI16,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	BTK	 	kinase	Inhibited	-2.000	 	0.123	-2.247	1.19E-04	IFI35,IRF9,OAS2,STAT1	BTK,MAPK1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	mir-155	 	microrna	 	-1.960	bias	-0.413	-1.151	1.35E-04	IRF7,IRF9,Mx1,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA17	 	cytokine	 	 	 	 	 	1.46E-04	EIF2AK2,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Stat1-Stat2	 	complex	 	 	 	 	 	1.46E-04	EIF2AK2,IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	UBA7	 	enzyme	 	 	 	 	 	1.46E-04	DDX58,DHX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NCOA2	 	transcription regulator	 	1.961	bias	0.387	1.202	1.57E-04	IFIT1B,IFIT2,Mx1,OASL	NCOA2,NR3C1	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Immunoglobulin	 	complex	 	-1.912	 	-0.002	-1.906	1.74E-04	EIF2AK2,IFIT1B,IFIT2,IRF7,Mx1,OAS2,RSAD2	Immunoglobulin,MYC,MYD88,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF2	 	transcription regulator	 	 	 	 	 	1.76E-04	EIF2AK2,IFI35,IRF7,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CpG ODN 1668	 	chemical reagent	 	 	 	 	 	1.78E-04	IRF7,STAT1,STAT2	CpG ODN 1668,IRF9,STAT1,STAT2	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL12A	 	cytokine	 	 	 	 	 	1.78E-04	IRF9,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL1B	 	cytokine	Activated	2.380	bias	0.270	1.737	1.84E-04	CMPK2,HELZ2,IFI16,IFIT1B,IRF7,OAS2,RSAD2,STAT1,USP18	IL1B,IL21,IRF3,IRF7,MYC,MYD88,SPI1,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MYC	 	transcription regulator	 	-1.036	bias	0.254	-1.741	2.09E-04	IFI16,IFI35,IFIT2,IRF7,IRF9,OASL,Oasl2,RSAD2,STAT1,USP18	MYC,STAT1,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SNCA	 	enzyme	 	-0.447	 	0.084	-0.634	2.46E-04	CTXN1,HPCA,IRF7,Nrgn,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL12B	 	cytokine	 	 	 	 	 	2.51E-04	IRF9,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TET2	 	enzyme	Inhibited	-2.000	bias	0.324	-2.648	2.75E-04	CMPK2,IFI16,IFIT2,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PCBP2	 	other	 	 	 	 	 	3.11E-04	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MUC1	 	other	 	 	 	 	 	3.41E-04	IFIT1B,OASL,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ATXN3	 	peptidase	 	 	 	 	 	3.80E-04	IFIT1B,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	fontolizumab	 	biologic drug	 	 	 	 	 	3.80E-04	IFI35,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CREBBP	 	transcription regulator	 	 	 	 	 	4.11E-04	IFIT1B,LGALS3BP,RSAD2,RTP4,SCN4B,USP18	CREBBP,EP300	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	decitabine	 	chemical drug	Activated	2.131	 	0.209	1.562	4.52E-04	EIF2AK2,IFI16,IFI35,IFIT2,IRF7,RTP4,STAT1,TJP2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF4	 	transcription regulator	 	-1.987	bias	-0.287	-1.416	4.72E-04	IRF7,IRF9,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	OSMR	 	transmembrane receptor	 	 	 	 	 	5.25E-04	DHX58,Irgm1,Oasl2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SB203580	 	chemical - kinase inhibitor	 	-1.633	bias	-0.516	 	5.52E-04	EIF2AK2,HPCA,IFI35,IFIT2,IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Map3k7	 	kinase	 	 	 	 	 	6.07E-04	CMPK2,IFIT2,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAPK9	 	kinase	 	-0.655	bias	0.281	-1.207	6.66E-04	IFI16,IRF9,LGALS3BP,PARP14	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EP300	 	transcription regulator	 	 	 	 	 	6.91E-04	IFIT1B,LGALS3BP,RSAD2,RTP4,SCN4B,USP18	CREBBP,EP300	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAP2K6	 	kinase	 	 	 	 	 	6.97E-04	IFIT2,IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	miR-199a-5p (and other miRNAs w/seed CCAGUGU)	 	mature microrna	 	 	 	 	 	7.96E-04	CMPK2,RSAD2,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	2-aminopurine	 	chemical reagent	 	 	 	 	 	8.21E-04	DDX58,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	mezerein	 	chemical - endogenous non-mammalian	 	 	 	 	 	8.21E-04	IRF9,OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	BRCA1	 	transcription regulator	 	 	 	 	 	8.49E-04	DDX58,IFIT2,IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Ifn gamma	 	complex	 	 	 	 	 	1.10E-03	EIF2AK2,STAT1,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL12 (complex)	 	complex	 	 	 	 	 	1.14E-03	IFIT1B,IFIT2,Mx1,Trim30a/Trim30d	IL12 (complex),STAT4	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	BCOR	 	transcription regulator	 	 	 	 	 	1.16E-03	DDX58,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM21	 	enzyme	 	 	 	 	 	1.16E-03	IRF7,Trim30a/Trim30d	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	fucoidin	 	chemical reagent	 	 	 	 	 	1.16E-03	IFIT1B,IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RARA	 	ligand-dependent nuclear receptor	 	-0.447	 	0.013	-0.476	1.63E-03	IFIT1B,LGALS3BP,RSAD2,RTP4,STAT1	CREBBP,EP300,RARA	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	KDM6B	 	enzyme	 	 	 	 	 	1.71E-03	OASL,Oasl2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	isobutylmethylxanthine	 	chemical toxicant	 	 	 	 	 	1.77E-03	IFIT2,IRF7,STAT1,STAT2	MAPK1,STAT3,isobutylmethylxanthine	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RNASEL	 	enzyme	 	 	 	 	 	1.86E-03	EIF2AK2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	USP18	2.255	peptidase	 	 	 	 	 	1.86E-03	IRF7,IRF9	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CHUK	 	kinase	 	1.969	bias	0.514	 	1.94E-03	IFI16,IFI35,IFIT1B,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TNF	 	cytokine	Activated	2.196	 	0.214	1.500	2.01E-03	DDX58,EIF2AK2,HPCA,IFI16,IFIT1B,IRF7,Mx1,OAS2,OASL,PARP14,STAT1	IFN Beta,IRF1,IRF7,Immunoglobulin,SOCS1,STAT1,STAT2,STAT3,STAT4,TNF	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PLK2	 	kinase	 	 	 	 	 	2.19E-03	CMPK2,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NPC2	 	transporter	 	 	 	 	 	2.36E-03	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PLK4	 	kinase	 	 	 	 	 	2.36E-03	CMPK2,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TAB1	 	enzyme	 	 	 	 	 	2.36E-03	IRF7,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CpG 10101	 	chemical drug	 	 	 	 	 	2.68E-03	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ETP-46464	 	chemical reagent	 	 	 	 	 	2.68E-03	OASL	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PTGES2	 	transcription regulator	 	 	 	 	 	2.68E-03	IRF9	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SLC15A4	 	transporter	 	 	 	 	 	2.68E-03	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	UBE2L6	 	enzyme	 	 	 	 	 	2.68E-03	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	USP13	 	peptidase	 	 	 	 	 	2.68E-03	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	recombinant interferon alpha	 	biologic drug	 	 	 	 	 	2.68E-03	RNF213	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	BAK1	 	other	 	 	 	 	 	2.72E-03	IRF7,Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRAK1	 	kinase	 	 	 	 	 	2.72E-03	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	cigarette smoke	 	chemical toxicant	 	1.951	bias	0.426	1.121	2.93E-03	OAS2,OASL,Oasl2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	interferon beta-1a	 	biologic drug	 	 	 	 	 	3.01E-03	IFI35,IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL27	 	cytokine	 	 	 	 	 	3.25E-03	EIF2AK2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Insulin	 	group	 	 	 	 	 	4.24E-03	IFIT2,IRF7,LGALS3BP,STAT1,STAT2	Insulin,JAK1,MAPK1,STAT1,STAT2,STAT3	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RARB	 	ligand-dependent nuclear receptor	 	 	 	 	 	4.44E-03	DDX58,STAT1,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Pam3-Cys-Ser-Lys4	 	chemical reagent	 	 	 	 	 	4.74E-03	IRF7,PARP14,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IKBKG	 	kinase	 	 	 	 	 	5.06E-03	IFI16,IFIT1B,IRF7	IKBKG,IRF3,TMEM173	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RICTOR	 	other	 	1.964	bias	-0.468	2.883	5.06E-03	IFI16,IFIT2,Mx1,OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	rosiglitazone	 	chemical drug	 	-1.000	 	0.220	-1.440	5.20E-03	IFIT2,IRF7,OAS2,STAT1,STAT2	JAK1,MAPK1,STAT1,STAT2,STAT3,rosiglitazone	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	9-benzyl-8-hydroxy-2-(2-methoxyethoxy)adenine	 	chemical reagent	 	 	 	 	 	5.35E-03	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	BMS-986126	 	chemical - kinase inhibitor	 	 	 	 	 	5.35E-03	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	COLEC12	 	transmembrane receptor	 	 	 	 	 	5.35E-03	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFN alpha receptor	 	complex	 	 	 	 	 	5.35E-03	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	KHDRBS2	 	other	 	 	 	 	 	5.35E-03	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MED6	 	transcription regulator	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MID2	 	other	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MKNK2	 	kinase	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MLST8	 	other	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SCARA3	 	transmembrane receptor	 	 	 	 	 	5.35E-03	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SCARA5	 	transmembrane receptor	 	 	 	 	 	5.35E-03	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM13	 	enzyme	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM32	 	transcription regulator	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM36	 	enzyme	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM5	 	enzyme	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM50	 	other	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM58	 	other	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM66	 	transcription regulator	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM67	 	other	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM9	 	enzyme	 	 	 	 	 	5.35E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	26s Proteasome	 	complex	 	 	 	 	 	6.22E-03	DDX58,IFI35,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PDCD1	 	phosphatase	 	 	 	 	 	6.45E-03	IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NR3C1	 	ligand-dependent nuclear receptor	Inhibited	-2.000	 	0.062	-2.125	6.63E-03	IFIT1B,IFIT2,JMJD6,Mx1,OASL,Trim30a/Trim30d	NCOA2,NR3C1	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NLRX1	 	other	 	 	 	 	 	6.73E-03	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	alefacept	 	biologic drug	 	 	 	 	 	7.02E-03	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EBI3	 	cytokine	 	 	 	 	 	7.31E-03	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MSC	 	transcription regulator	 	 	 	 	 	7.92E-03	IRF7,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Eif2	 	complex	 	 	 	 	 	8.01E-03	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	FSCN1	 	other	 	 	 	 	 	8.01E-03	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	HERC5	 	enzyme	 	 	 	 	 	8.01E-03	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	KPNA1	 	transporter	 	 	 	 	 	8.01E-03	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SATB1	 	transcription regulator	 	 	 	 	 	8.08E-03	HELZ2,IRF7,XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	levodopa	 	chemical - endogenous mammalian	Inhibited	-2.449	 	0.068	-2.616	8.13E-03	ARPP21,C2CD2L,CTXN1,HPCA,Oasl2,SCN4B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	BAX	 	transporter	 	 	 	 	 	8.22E-03	IRF7,Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CpG ODN 1826	 	chemical reagent	 	 	 	 	 	8.54E-03	IRF7,PARP14	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	UCP1	 	transporter	 	 	 	 	 	9.27E-03	DDX58,IFIT1B,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EFNA1	 	other	 	 	 	 	 	1.02E-02	HERC6,IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MAP2K3	 	kinase	 	 	 	 	 	1.05E-02	IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DNAJB4	 	other	 	 	 	 	 	1.07E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	GPR17	 	g-protein coupled receptor	 	 	 	 	 	1.07E-02	XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	HLA-B	 	transmembrane receptor	 	 	 	 	 	1.07E-02	OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL12RB1	 	transmembrane receptor	 	 	 	 	 	1.07E-02	OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Ifna4	 	other	 	 	 	 	 	1.07E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NLRP11	 	other	 	 	 	 	 	1.07E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SLCO1C1	 	transporter	 	 	 	 	 	1.07E-02	Nrgn	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	poly rI:rC-RNA HMW	 	chemical reagent	 	 	 	 	 	1.07E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	polyinosine-polycytidylic acid/polyethylenimine formulation	 	chemical reagent	 	 	 	 	 	1.07E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	sulfamethoxazole/trimethoprim	 	chemical drug	 	 	 	 	 	1.07E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	E. coli serotype 0127B8 lipopolysaccharide	 	chemical - endogenous non-mammalian	 	 	 	 	 	1.25E-02	RSAD2,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRAK4	 	kinase	 	 	 	 	 	1.27E-02	IFIT1B,IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IRF3 dimer	 	complex	 	 	 	 	 	1.33E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ISG15	 	other	 	 	 	 	 	1.33E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	KRAS	 	enzyme	 	-1.109	 	0.037	-1.192	1.43E-02	EIF2AK2,IRF9,STAT1,STAT2,Trim30a/Trim30d	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TCF4	 	transcription regulator	 	 	 	 	 	1.46E-02	DDX58,IFI16,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SOCS3	 	phosphatase	 	 	 	 	 	1.47E-02	IFIT2,OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RELA	 	transcription regulator	 	 	 	 	 	1.50E-02	IFIT1B,IRF7,Mx1,OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Tlr	 	group	 	 	 	 	 	1.51E-02	IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	R5020	 	chemical reagent	 	 	 	 	 	1.55E-02	LGALS3BP,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	5R-hydroxytriptolide	 	chemical drug	 	 	 	 	 	1.60E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA10	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA14	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA16	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA21	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA5	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA6	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA7	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNA8	 	cytokine	 	 	 	 	 	1.60E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SLC19A1	 	transporter	 	 	 	 	 	1.60E-02	Trim30a/Trim30d	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM8	 	other	 	 	 	 	 	1.60E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	mito-TEMPO	 	chemical reagent	 	 	 	 	 	1.60E-02	Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SOX1	 	transcription regulator	 	 	 	 	 	1.63E-02	Oasl2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	H2AFY	 	other	 	 	 	 	 	1.85E-02	IRF7,TJP2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NR1H3	 	ligand-dependent nuclear receptor	 	 	 	 	 	1.86E-02	IFIT2,IRF7,ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	G3BP1	 	enzyme	 	 	 	 	 	1.86E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	HDAC11	 	transcription regulator	 	 	 	 	 	1.86E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RP 73401	 	chemical toxicant	 	 	 	 	 	1.86E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM25	 	transcription regulator	 	 	 	 	 	1.86E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SOX3	 	transcription regulator	 	 	 	 	 	1.90E-02	Oasl2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	REL	 	transcription regulator	 	 	 	 	 	1.90E-02	IFIT1B,PARP14,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	GMNN	 	transcription regulator	 	 	 	 	 	2.03E-02	Oasl2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	prednisolone	 	chemical drug	 	 	 	 	 	2.07E-02	IFIT1B,Irgm1,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NPC1	 	transporter	 	 	 	 	 	2.08E-02	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CYTOR	 	other	 	 	 	 	 	2.12E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DDB1	 	other	 	 	 	 	 	2.12E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	FBXO42	 	other	 	 	 	 	 	2.12E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SAMHD1	 	enzyme	 	 	 	 	 	2.12E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TBL1X	 	transcription regulator	 	 	 	 	 	2.12E-02	USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TBL1XR1	 	transcription regulator	 	 	 	 	 	2.12E-02	USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PDLIM2	 	other	 	 	 	 	 	2.27E-02	LGALS3BP,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IKZF1	 	transcription regulator	 	 	 	 	 	2.30E-02	IFI16,RNF213,RTP4	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NFKB1	 	transcription regulator	 	 	 	 	 	2.30E-02	IFIT1B,Mx1,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ANGPTL4	 	other	 	 	 	 	 	2.39E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CHRNA3	 	transmembrane receptor	 	 	 	 	 	2.39E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MTORC2	 	complex	 	 	 	 	 	2.39E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RNASEH2B	 	enzyme	 	 	 	 	 	2.39E-02	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TAP1	 	transporter	 	 	 	 	 	2.39E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ZBP1	1.575	other	 	 	 	 	 	2.39E-02	Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Histone h3	 	group	 	 	 	 	 	2.62E-02	Ifi27l2a/Ifi27l2b,IRF7,RSAD2,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DLK1	 	other	 	 	 	 	 	2.65E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IFNW1	 	cytokine	 	 	 	 	 	2.65E-02	ZBP1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SLC6A1	 	transporter	 	 	 	 	 	2.65E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TRIM38	 	other	 	 	 	 	 	2.65E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	VASP	 	other	 	 	 	 	 	2.65E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	aphidicolin	 	chemical toxicant	 	 	 	 	 	2.65E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	estriol	 	chemical - endogenous mammalian	 	 	 	 	 	2.65E-02	SDC3	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	GFI1	 	transcription regulator	 	 	 	 	 	2.67E-02	EIF2AK2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	sirolimus	 	chemical drug	Inhibited	-2.000	bias	-0.379	-1.241	2.82E-02	EIF2AK2,IRF7,IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	2'3'-cyclic guanosine monophosphate-adenosine monophosphate	 	chemical - endogenous mammalian	 	 	 	 	 	2.91E-02	RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MVP	 	other	 	 	 	 	 	2.91E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PIK3R2	 	kinase	 	 	 	 	 	2.91E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CLOCK	 	transcription regulator	 	 	 	 	 	2.92E-02	JMJD6,SCN4B,Trim30a/Trim30d	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL6	 	cytokine	 	1.951	bias	0.335	1.298	3.13E-02	IFI16,IFIT1B,IFIT2,IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	AFAP1-AS1	 	other	 	 	 	 	 	3.17E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DDB2	 	other	 	 	 	 	 	3.17E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NELFB	 	other	 	 	 	 	 	3.17E-02	Ifi27l2a/Ifi27l2b	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PLCG2	 	enzyme	 	 	 	 	 	3.17E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RMRP	 	other	 	 	 	 	 	3.17E-02	RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DUSP1	 	phosphatase	 	 	 	 	 	3.22E-02	CMPK2,HELZ2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PRKCA	 	kinase	 	 	 	 	 	3.22E-02	OASL,RSAD2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	CpG oligonucleotide	 	chemical drug	 	 	 	 	 	3.27E-02	JMJD6,Trim30a/Trim30d	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	3M-002	 	chemical reagent	 	 	 	 	 	3.43E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RYR2	 	ion channel	 	 	 	 	 	3.43E-02	SCN4B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	aroclor 1254	 	chemical toxicant	 	 	 	 	 	3.43E-02	Nrgn	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PARP1	 	enzyme	 	 	 	 	 	3.56E-02	LGALS3BP,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RAS	 	group	 	 	 	 	 	3.68E-02	STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DNAJC3	 	other	 	 	 	 	 	3.69E-02	Nrgn	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	IL18R1	 	transmembrane receptor	 	 	 	 	 	3.69E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NLRC5	1.483	transcription regulator	 	 	 	 	 	3.69E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Ptprd	 	phosphatase	 	 	 	 	 	3.69E-02	IFI35	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ZNF148	 	transcription regulator	 	 	 	 	 	3.69E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DHX9	 	enzyme	 	 	 	 	 	3.94E-02	XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	KIF1B	 	transporter	 	 	 	 	 	3.94E-02	XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RAG1	 	enzyme	 	 	 	 	 	3.94E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	melphalan	 	chemical drug	 	 	 	 	 	3.94E-02	XAF1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TERT	 	enzyme	 	 	 	 	 	4.10E-02	IFI16,IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	OSM	 	cytokine	 	1.941	 	0.215	1.524	4.15E-02	IFI35,IRF7,IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	3M-011	 	chemical reagent	 	 	 	 	 	4.20E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	DPH5	 	enzyme	 	 	 	 	 	4.20E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EIF2S1	 	translation regulator	 	 	 	 	 	4.20E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Smad2/3-Smad4	 	complex	 	 	 	 	 	4.20E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	Z-LLL-CHO	 	chemical - protease inhibitor	 	 	 	 	 	4.42E-02	IRF7,STAT1,STAT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	3-deoxy-2-octulosonic acid(2)-lipid A	 	chemical - endogenous non-mammalian	 	 	 	 	 	4.46E-02	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EMD	 	other	 	 	 	 	 	4.46E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	LAMA5	 	other	 	 	 	 	 	4.46E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MSR1	 	transmembrane receptor	 	 	 	 	 	4.46E-02	IFIT1B	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ORMDL3	 	other	 	 	 	 	 	4.46E-02	OAS2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	TOR1A	 	enzyme	 	 	 	 	 	4.46E-02	Nrgn	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	leptomycin B	 	chemical drug	 	 	 	 	 	4.46E-02	IFIT2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ssRNA40	 	chemical reagent	 	 	 	 	 	4.46E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SP110	 	transcription regulator	 	 	 	 	 	4.48E-02	IRF9,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	mibolerone	 	chemical drug	 	 	 	 	 	4.48E-02	IRF7,USP18	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	HNRNPA1	 	enzyme	 	 	 	 	 	4.72E-02	EIF2AK2	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PARG	 	enzyme	 	 	 	 	 	4.72E-02	LGALS3BP	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	RPA1	 	other	 	 	 	 	 	4.72E-02	ADGRG5	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	SGPL1	 	enzyme	 	 	 	 	 	4.72E-02	DDX58	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EBF1	 	transcription regulator	 	 	 	 	 	4.74E-02	IRF7,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	geldanamycin	 	chemical - endogenous non-mammalian	 	 	 	 	 	4.74E-02	IFIT2,STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	ACKR1	 	g-protein coupled receptor	 	 	 	 	 	4.97E-02	IFI16	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	EIF4EBP2	 	translation regulator	 	 	 	 	 	4.97E-02	IRF7	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	MLX	 	transcription regulator	 	 	 	 	 	4.97E-02	LGALS3BP	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	NUMB	 	other	 	 	 	 	 	4.97E-02	IFI16	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	PTPN22	 	phosphatase	 	 	 	 	 	4.97E-02	Mx1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	zidovudine	 	chemical drug	 	 	 	 	 	4.97E-02	STAT1	 	
R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	 	P38 MAPK	 	group	 	 	 	 	 	5.00E-02	IRF7,STAT1,TJP2	 	

Causal Networks for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM

Diseases and Bio Functions for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Antimicrobial Response, Inflammatory Response	antiviral response	Antiviral response	4.35E-20	Increased	2.189	bias	1.194	EIF2AK2,RSAD2,DHX58,IFIT1B,OASL,STAT2,OAS2,DDX58,IFIT2,Ifi27l2a/Ifi27l2b,RTP4,IRF7,Mx1,STAT1,Oasl2,IFI16	16	
Immunological Disease	systemic autoimmune syndrome	Systemic autoimmune syndrome	6.66E-18	 	 	 	 	EIF2AK2,RSAD2,IFIT1B,NLRC5,IFIT2,USP18,Trim30a/Trim30d,Ifi27l2a/Ifi27l2b,RTP4,IRF7,XAF1,SLFN5,STAT1,PARP14,LGALS3BP,SDC3,PARP12,DHX58,OASL,STAT2,OAS2,DDX58,HELZ2,HERC6,Irgm1,Oasl2,ZBP1,IFI16	28	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	systemic lupus erythematosus	Systemic lupus erythematosus	1.26E-12	 	 	 	 	PARP12,EIF2AK2,RSAD2,DHX58,OASL,NLRC5,OAS2,DDX58,USP18,HERC6,IRF7,STAT1,ZBP1,IFI16	14	
Endocrine System Disorders, Gastrointestinal Disease, Immunological Disease, Metabolic Disease, Organismal Injury and Abnormalities	insulin-dependent diabetes mellitus	Insulin-dependent diabetes mellitus	1.65E-12	 	 	 	 	IFIT1B,STAT2,IFIT2,Trim30a/Trim30d,Ifi27l2a/Ifi27l2b,RTP4,HERC6,Irgm1,IRF7,XAF1,STAT1,Oasl2,ZBP1,PARP14,IFI16	15	
Infectious Diseases	replication	Replication of Herpesviridae	6.85E-12	 	-1.913	 	-1.297	PARP12,RSAD2,IRF9,OASL,STAT1,STAT2,DDX58,ZBP1	8	
Infectious Diseases	infection	Infection of mammalia	5.53E-09	Decreased	-2.605	bias	-1.450	EIF2AK2,IRF9,DHX58,Irgm1,IRF7,OASL,STAT1,STAT2,DDX58,IFIT2,USP18	11	
Infectious Diseases	replication	Replication of virus	1.12E-08	Decreased	-3.047	bias	-4.010	PARP12,EIF2AK2,RSAD2,IRF9,OASL,NLRC5,STAT2,DDX58,IRF7,Mx1,STAT1,Oasl2,ZBP1	13	
Infectious Diseases	tuberculosis	Tuberculosis	1.12E-08	 	 	 	 	Irgm1,IRF7,STAT1,STAT2,IFI35,OAS2,IFIT2,IFI16	8	
Infectious Diseases	replication	Replication of vesicular stomatitis virus	1.18E-08	Decreased	-2.273	bias	-1.300	PARP12,IRF9,OASL,Oasl2,STAT2,DDX58	6	
Protein Synthesis	quantity	Quantity of IL-12 in blood	2.86E-08	 	-1.342	 	-0.976	DHX58,Irgm1,STAT1,IFIT2,LGALS3BP	5	
Infectious Diseases	replication	Replication of RNA virus	3.33E-08	Decreased	-2.853	bias	-3.840	PARP12,EIF2AK2,RSAD2,IRF9,IRF7,Mx1,STAT1,OASL,Oasl2,NLRC5,STAT2,DDX58	12	
Connective Tissue Disorders, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	rheumatic disease	Rheumatic Disease	4.56E-08	 	 	 	 	PARP12,EIF2AK2,DHX58,RSAD2,OASL,NLRC5,OAS2,DDX58,USP18,HELZ2,HERC6,IRF7,SLFN5,STAT1,SCN4B,ZBP1,IFI16,SDC3	18	
Inflammatory Response	innate immune response	Innate immune response	6.72E-08	 	1.982	bias	 	EIF2AK2,IRF7,Mx1,STAT1,NLRC5,DDX58,ZBP1,IFIT2	8	
Cell Signaling	replication	Replication of viral replicon	9.41E-08	Decreased	-2.207	bias	-1.556	EIF2AK2,RSAD2,Mx1,OASL,IFI16	5	
Dermatological Diseases and Conditions, Immunological Disease, Organismal Injury and Abnormalities	pemphigus foliaceus	Pemphigus foliaceus	2.95E-07	 	 	 	 	EIF2AK2,RSAD2,STAT1,OASL,OAS2	5	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	psoriasis	Psoriasis	3.13E-07	 	 	 	 	RTP4,HERC6,RSAD2,IRF7,STAT1,OASL,IFI35,OAS2,DDX58,LGALS3BP,IFI16	11	
Cancer, Dermatological Diseases and Conditions, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	cutaneous T-cell lymphoma	Cutaneous T-cell lymphoma	4.41E-07	 	 	 	 	RSAD2,IRF7,OASL,STAT1,IFI35,OAS2	6	
Endocrine System Disorders, Gastrointestinal Disease, Metabolic Disease, Organismal Injury and Abnormalities	diabetes mellitus	Diabetes mellitus	7.24E-07	 	 	 	 	RSAD2,IFIT1B,STAT2,IFIT2,Trim30a/Trim30d,Ifi27l2a/Ifi27l2b,RTP4,HERC6,IRF7,Irgm1,XAF1,STAT1,Oasl2,PARP14,ZBP1,IFI16	16	
Metabolic Disease, Organismal Injury and Abnormalities	glucose metabolism disorder	Glucose metabolism disorder	2.62E-06	 	 	 	 	EIF2AK2,RSAD2,IFIT1B,STAT2,IFIT2,Trim30a/Trim30d,Ifi27l2a/Ifi27l2b,RTP4,HERC6,IRF7,Irgm1,XAF1,STAT1,Oasl2,PARP14,ZBP1,IFI16	17	
Antimicrobial Response, Inflammatory Response	antiviral response	Antiviral response of cells	4.54E-06	 	1.982	bias	1.252	EIF2AK2,DHX58,STAT1,DDX58	4	
Infectious Diseases	replication	Replication of Simian virus 5 strain W3a	6.61E-06	 	 	 	 	IRF9,STAT2	2	
Infectious Diseases	replication	Replication of human parainfluenza virus	6.61E-06	 	 	 	 	IRF9,STAT2	2	
Infectious Diseases	infection	Viral Infection	9.06E-06	Decreased	-3.124	bias	-4.716	PARP12,EIF2AK2,IRF9,DHX58,RSAD2,OASL,NLRC5,STAT2,OAS2,DDX58,IFIT2,IRF7,Mx1,STAT1,Oasl2,IFI35,ZBP1	17	
Protein Synthesis	quantity	Quantity of IFNG in blood	9.80E-06	 	-1.941	 	-1.596	DHX58,Irgm1,STAT1,LGALS3BP	4	
Cell Cycle, Gene Expression	binding	Binding of interferon-stimulated response element	1.09E-05	 	 	 	 	IRF9,STAT1,DDX58	3	
Cell Death and Survival	apoptosis	Apoptosis of fibrosarcoma cell lines	1.52E-05	 	 	 	 	EIF2AK2,STAT1,STAT2,DDX58	4	
Antimicrobial Response, Cell-To-Cell Signaling and Interaction, Connective Tissue Development and Function, Inflammatory Response	antiviral response	Antiviral response of fibroblasts	1.98E-05	 	 	 	 	STAT1,DDX58	2	
Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	contact growth inhibition	Contact growth inhibition of lymphoma cell lines	1.98E-05	 	 	 	 	STAT1,DDX58	2	
Infectious Diseases	replication	Replication of human herpesvirus 1	2.11E-05	 	 	 	 	IRF9,OASL,STAT2	3	
Inflammatory Response	interferon response	Interferon response	2.80E-05	 	 	 	 	EIF2AK2,IRF7,DDX58	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	mature T-cell neoplasm	Mature T-cell neoplasm	5.15E-05	 	 	 	 	RSAD2,IRF7,STAT1,OASL,STAT2,IFI35,OAS2,IFIT2	8	
Infectious Diseases	replication	Replication of Flaviviridae	5.43E-05	 	-1.922	 	-1.969	EIF2AK2,RSAD2,OASL,DDX58	4	
Infectious Diseases	infection	Infection of fibrosarcoma cell lines	6.58E-05	 	 	 	 	STAT1,STAT2	2	
Infectious Diseases	replication	Replication of Myxoma virus	6.58E-05	 	 	 	 	EIF2AK2,STAT1	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	T-cell non-Hodgkin disease	T-cell non-Hodgkin lymphoma	6.62E-05	 	 	 	 	RSAD2,IRF7,STAT1,OASL,STAT2,IFI35,OAS2,IFIT2	8	
Infectious Diseases	replication	Replication of Paramyxoviridae	1.10E-04	 	 	 	 	IRF9,OASL,STAT2	3	
Infectious Diseases	replication	Replication of Human cytomegalovirus	1.38E-04	 	 	 	 	RSAD2,ZBP1	2	
Protein Synthesis	quantity	Quantity of cytokine	1.48E-04	 	-1.190	 	-1.136	DHX58,Irgm1,STAT1,IFIT2,LGALS3BP,HELZ2	6	
Hematological Disease, Immunological Disease	primary antiphospholipid antibody syndrome	Primary antiphospholipid antibody syndrome	1.63E-04	 	 	 	 	STAT1,OAS2,LGALS3BP	3	
Infectious Diseases	replication	Replication of Influenza A virus	1.81E-04	Decreased	-2.178	bias	-3.222	EIF2AK2,RSAD2,Mx1,STAT1,NLRC5,DDX58	6	
Neurological Disease, Organismal Injury and Abnormalities	calcification	Calcification of brain	1.83E-04	 	 	 	 	STAT1,USP18	2	
Infectious Diseases	infection	Infection by chlamydia	2.35E-04	 	 	 	 	Irgm1,STAT1	2	
Organismal Survival	survival	Survival of organism	2.78E-04	 	1.213	 	0.580	DHX58,RSAD2,IRF7,Irgm1,Mx1,STAT1,NLRC5,STAT2,DDX58,IFI16	10	
Gene Expression	transactivation	Transactivation of RNA	3.66E-04	 	1.724	bias	0.962	EIF2AK2,IRF9,IRF7,STAT1,STAT2,DDX58,IFI16,JMJD6	8	
Cell Cycle, Cellular Growth and Proliferation	antiproliferative response	Antiproliferative response of cells	5.07E-04	 	 	 	 	STAT1,STAT2	2	
Connective Tissue Disorders, Infectious Diseases, Organismal Injury and Abnormalities	infection	Infection of fibroblasts	5.07E-04	 	 	 	 	EIF2AK2,DDX58	2	
Protein Synthesis	quantity	Quantity of IL-12b in blood	5.07E-04	 	 	 	 	STAT1,IFIT2	2	
Inflammatory Response	type I interferon response	Type I interferon response	5.07E-04	 	 	 	 	IRF7,DDX58	2	
Infectious Diseases	replication	Replication of flavivirus	5.90E-04	 	 	 	 	RSAD2,OASL	2	
Infectious Diseases	replication	Replication of Murine herpesvirus 4	6.80E-04	 	 	 	 	PARP12,DDX58	2	
Infectious Diseases	replication	Replication of Hepatitis C virus	7.62E-04	 	 	 	 	EIF2AK2,RSAD2,DDX58	3	
Cell Death and Survival, DNA Replication, Recombination, and Repair	fragmentation	Fragmentation of genomic DNA	7.75E-04	 	 	 	 	EIF2AK2,STAT1	2	
Cellular Growth and Proliferation	cytostasis	Cytostasis of tumor cell lines	9.74E-04	 	1.452	bias	0.941	EIF2AK2,STAT1,DDX58,IFI16	4	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of natural killer T lymphocytes	9.85E-04	 	 	 	 	STAT1,DDX58	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	non-Hodgkin disease	Non-Hodgkin lymphoma	1.00E-03	 	 	 	 	RSAD2,IRF7,STAT1,ARPP21,OASL,STAT2,IFI35,OAS2,RNF213,DDX58,IFIT2	11	
Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	contact growth inhibition	Contact growth inhibition	1.02E-03	 	1.490	 	1.154	Irgm1,STAT1,DDX58,IFI16	4	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin carcinoma	Skin carcinoma	1.11E-03	 	 	 	 	HERC6,DHX58,RSAD2,IRF7,STAT1,OASL,NLRC5,IFI35,OAS2,RNF213,CMPK2	11	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphoma	Lymphoma	1.29E-03	 	 	 	 	RSAD2,IRF7,STAT1,ARPP21,OASL,STAT2,IFI35,OAS2,RNF213,DDX58,PARP14,IFIT2	12	
Cell Cycle	replication	Replication of cells	1.30E-03	 	 	 	 	IRF7,Irgm1,STAT1	3	
Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	contact growth inhibition	Contact growth inhibition of tumor cell lines	1.44E-03	 	 	 	 	STAT1,DDX58,IFI16	3	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	basal cell carcinoma	Basal cell carcinoma	1.45E-03	 	 	 	 	RSAD2,IRF7,STAT1,OASL,NLRC5,IFI35,OAS2	7	
Cellular Growth and Proliferation	cytostasis	Cytostasis	1.61E-03	Increased	2.088	 	1.613	EIF2AK2,Irgm1,STAT1,DDX58,IFI16	5	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of T lymphocytes	1.71E-03	 	 	 	 	RSAD2,STAT1,STAT2,DDX58,USP18,JMJD6	6	
Hematological System Development and Function, Lymphoid Tissue Structure and Development, Tissue Morphology	number	Number of activated T lymphocyte	1.76E-03	 	 	 	 	STAT1,DDX58	2	
Protein Synthesis	quantity	Quantity of protein in blood	1.93E-03	 	-0.483	 	-0.353	DHX58,Irgm1,STAT1,IFIT2,LGALS3BP,SDC3,HELZ2	7	
Cellular Development, Cellular Growth and Proliferation	proliferation	Proliferation of fibrosarcoma cell lines	2.07E-03	 	 	 	 	STAT1,STAT2	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	hematopoiesis	Hematopoiesis of phagocytes	2.19E-03	 	 	 	 	IRF7,STAT1,IFI16,USP18	4	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	development	Development of TREG cells	2.23E-03	 	 	 	 	STAT1,DDX58	2	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	hyperplasia	Hyperplasia of hematopoietic progenitor cells	2.23E-03	 	 	 	 	Irgm1,STAT1	2	
Cell Cycle, Gene Expression	binding	Binding of E box motif	2.57E-03	 	 	 	 	STAT1,IFI16	2	
Infectious Diseases	activation	Activation of hepatitis B virus	2.60E-03	 	 	 	 	STAT1	1	
Organismal Development	aging	Aging of brain	2.60E-03	 	 	 	 	EIF2AK2	1	
Cell Cycle, Cellular Growth and Proliferation	antiproliferative response	Antiproliferative response of fibrosarcoma cell lines	2.60E-03	 	 	 	 	STAT2	1	
Antimicrobial Response, Cell-To-Cell Signaling and Interaction, Inflammatory Response	antiviral response	Antiviral response of macrophages	2.60E-03	 	 	 	 	DDX58	1	
Cell Morphology, Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	architecture	Architecture of junctional complexes	2.60E-03	 	 	 	 	TJP2	1	
Cell Cycle, Reproductive System Development and Function	G2/M phase transition	Arrest in G2/M phase transition of gonadal cell lines	2.60E-03	 	 	 	 	EIF2AK2	1	
Hereditary Disorder, Infectious Diseases, Organismal Injury and Abnormalities	autosomal dominant atypical mycobacteriosis	Autosomal dominant atypical mycobacteriosis	2.60E-03	 	 	 	 	STAT1	1	
Hereditary Disorder, Infectious Diseases, Organismal Injury and Abnormalities	autosomal recessive susceptibility to mycobacterial and viral infections	Autosomal recessive susceptibility to mycobacterial and viral infections	2.60E-03	 	 	 	 	STAT1	1	
Cell Death and Survival	cell death	Cell death of satellite cells	2.60E-03	 	 	 	 	SDC3	1	
Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry	conjugation	Conjugation of phosphatidylethanolamine	2.60E-03	 	 	 	 	Irgm1	1	
Cancer, Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	contact growth inhibition	Contact growth inhibition of acute promyelocytic leukemia cells	2.60E-03	 	 	 	 	DDX58	1	
Cell Cycle	G0/G1 phase transition	Delay in G0/G1 phase transition of leukemia cell lines	2.60E-03	 	 	 	 	STAT1	1	
Dermatological Diseases and Conditions, Hereditary Disorder, Immunological Disease, Infectious Diseases, Organismal Injury and Abnormalities	familial candidiasis type 7	Familial candidiasis type 7	2.60E-03	 	 	 	 	STAT1	1	
Cellular Growth and Proliferation	growth	Growth of insect cells	2.60E-03	 	 	 	 	EIF2AK2	1	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	immunodeficiency 31A	Immunodeficiency 31A	2.60E-03	 	 	 	 	STAT1	1	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	immunodeficiency 39	Immunodeficiency 39	2.60E-03	 	 	 	 	IRF7	1	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	immunodeficiency 44	Immunodeficiency 44	2.60E-03	 	 	 	 	STAT2	1	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	inflammation	Inflammation of forebrain	2.60E-03	 	 	 	 	IRF9	1	
Antimicrobial Response	inhibition	Inhibition of Reoviridae	2.60E-03	 	 	 	 	EIF2AK2	1	
Cardiovascular Disease, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities	long-QT syndrome 10	Long-QT syndrome 10	2.60E-03	 	 	 	 	SCN4B	1	
Hematological Disease	lymphomyeloid failure	Lymphomyeloid failure	2.60E-03	 	 	 	 	Irgm1	1	
Nervous System Development and Function, Organ Morphology, Organismal Development	morphology	Morphology of lamina III	2.60E-03	 	 	 	 	SDC3	1	
Cardiovascular Disease, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	moyamoya disease type 2	Moyamoya disease type 2	2.60E-03	 	 	 	 	RNF213	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	phosphorylation	Phosphorylation of dUMP	2.60E-03	 	 	 	 	CMPK2	1	
Drug Metabolism, Nucleic Acid Metabolism, Small Molecule Biochemistry	phosphorylation	Phosphorylation of floxuridine	2.60E-03	 	 	 	 	CMPK2	1	
Cancer, Organismal Injury and Abnormalities	head and neck squamous cell carcinoma	Poorly differentiated head and neck squamous cell carcinoma	2.60E-03	 	 	 	 	DDX58	1	
Gastrointestinal Disease, Hepatic System Disease, Hereditary Disorder, Organismal Injury and Abnormalities	progressive familial intrahepatic cholestasis type 4	Progressive familial intrahepatic cholestasis type 4	2.60E-03	 	 	 	 	TJP2	1	
Cellular Growth and Proliferation	proliferation	Proliferation of Leishmania amazonensis (WHOM/BR/75/Josefa)	2.60E-03	 	 	 	 	EIF2AK2	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Organismal Development, Tissue Development	proliferation	Proliferation of metanephric mesenchymal cells	2.60E-03	 	 	 	 	STAT1	1	
Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	pseudo-TORCH syndrome type 2	Pseudo-TORCH syndrome type 2	2.60E-03	 	 	 	 	USP18	1	
Tissue Morphology	quantity	Quantity of Francisella novicida U112	2.60E-03	 	 	 	 	STAT1	1	
Drug Metabolism	removal	Removal of cisplatin	2.60E-03	 	 	 	 	EIF2AK2	1	
Infectious Diseases	replication	Replication of Thogoto virus	2.60E-03	 	 	 	 	Mx1	1	
Infectious Diseases	resistance to Encephalomyocarditis virus	Resistance to Encephalomyocarditis virus	2.60E-03	 	 	 	 	OAS2	1	
Cell Cycle	S phase	S phase of satellite cells	2.60E-03	 	 	 	 	SDC3	1	
Cell-To-Cell Signaling and Interaction	sensitization	Sensitization of myeloma cell lines	2.60E-03	 	 	 	 	PARP14	1	
Cardiovascular Disease, Connective Tissue Disorders, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Singleton-Merten syndrome type 2	Singleton-Merten syndrome type 2	2.60E-03	 	 	 	 	DDX58	1	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	survival	Survival of myeloma cells	2.60E-03	 	 	 	 	PARP14	1	
RNA Post-Transcriptional Modification	unwinding	Unwinding of siRNA	2.60E-03	 	 	 	 	DDX58	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of Th17 cells	2.92E-03	 	 	 	 	STAT1,DDX58,USP18	3	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	hematopoiesis	Hematopoiesis of mononuclear leukocytes	2.95E-03	 	1.857	bias	1.257	RSAD2,IRF7,STAT1,STAT2,DDX58,USP18,IFI16,JMJD6	8	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of helper T lymphocytes	2.99E-03	 	 	 	 	RSAD2,STAT1,DDX58,USP18	4	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Renal and Urological Disease, Skeletal and Muscular Disorders	systemic lupus erythematosus nephritis	Systemic lupus erythematosus nephritis	3.32E-03	 	 	 	 	PARP12,IRF7	2	
Cell Death and Survival	apoptosis	Apoptosis of tumor cell lines	3.50E-03	 	1.230	 	1.482	EIF2AK2,Irgm1,XAF1,STAT1,STAT2,HPCA,DDX58,PARP14,LGALS3BP,USP18,IFI16	11	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	development	Development of Th17 cells	3.73E-03	 	 	 	 	STAT1,DDX58	2	
Cell Cycle	cell cycle progression	Arrest in cell cycle progression	4.36E-03	 	 	 	 	EIF2AK2,IRF9,IRF7,STAT1,IFI16	5	
Inflammatory Response	immune response	Immune response of brain	4.49E-03	 	-0.328	 	-0.495	IRF9,Irgm1,STAT1,STAT2,USP18	5	
Cellular Function and Maintenance	function	Function of leukocytes	5.07E-03	 	 	 	 	IRF7,STAT1,NLRC5,STAT2,DDX58,Trim30a/Trim30d	6	
Neurological Disease, Organismal Injury and Abnormalities	neurodegeneration	Neurodegeneration of brain	5.07E-03	 	 	 	 	IRF9,STAT1,HPCA	3	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of antigen presenting cells	5.09E-03	 	 	 	 	EIF2AK2,STAT1	2	
Cell Death and Survival	excitotoxicity	Susceptibility to excitotoxicity of neurons	5.09E-03	 	 	 	 	STAT1,HPCA	2	
Digestive System Development and Function, Hepatic System Development and Function, Organ Morphology, Organismal Development	abnormal size	Abnormal size of liver	5.20E-03	 	 	 	 	HELZ2	1	
Antimicrobial Response, Cell-To-Cell Signaling and Interaction, Inflammatory Response	antiviral response	Antiviral response of myeloid dendritic cells	5.20E-03	 	 	 	 	DDX58	1	
Cell Cycle, Reproductive System Development and Function	G0/G1 phase transition	Arrest in G0/G1 phase transition of gonadal cell lines	5.20E-03	 	 	 	 	EIF2AK2	1	
Cell Cycle	cell cycle progression	Arrest in cell cycle progression of thyroid tumor cell lines	5.20E-03	 	 	 	 	IFI16	1	
Cell Cycle, Gene Expression	binding	Binding of NF-GMa-binding site	5.20E-03	 	 	 	 	STAT1	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	biosynthesis	Biosynthesis of dTDP	5.20E-03	 	 	 	 	CMPK2	1	
Cell Cycle, Nervous System Development and Function	cell cycle progression	Cell cycle progression of satellite cells	5.20E-03	 	 	 	 	SDC3	1	
Dermatological Diseases and Conditions, Infectious Diseases, Inflammatory Disease, Inflammatory Response, Ophthalmic Disease, Organismal Injury and Abnormalities	cellulitis	Cellulitis of eye	5.20E-03	 	 	 	 	STAT1	1	
Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	contact growth inhibition	Contact growth inhibition of thyroid tumor cell lines	5.20E-03	 	 	 	 	IFI16	1	
Cellular Growth and Proliferation, Connective Tissue Development and Function	cytostasis	Cytostasis of chondrocytes	5.20E-03	 	 	 	 	STAT1	1	
Cellular Growth and Proliferation	cytostasis	Cytostasis of rhabdomyosarcoma cell lines	5.20E-03	 	 	 	 	STAT1	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	lymphomagenesis	Delay in initiation of lymphomagenesis of B-cell lymphoma	5.20E-03	 	 	 	 	PARP14	1	
Cellular Development, Tissue Development	differentiation	Differentiation of thymic medullary epithelial cells	5.20E-03	 	 	 	 	IRF7	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	dystonia mysculorum deformans 2	Dystonia mysculorum deformans 2	5.20E-03	 	 	 	 	HPCA	1	
Cell Death and Survival, DNA Replication, Recombination, and Repair	fragmentation	Fragmentation of chromosomal DNA	5.20E-03	 	 	 	 	EIF2AK2	1	
Inflammatory Response	frequency	Frequency of conventional dendritic cells	5.20E-03	 	 	 	 	USP18	1	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of bone marrow-derived dendritic cells	5.20E-03	 	 	 	 	STAT1	1	
Antimicrobial Response	inhibition	Inhibition of vesicular stomatitis virus	5.20E-03	 	 	 	 	EIF2AK2	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long-term potentiation	Long-term potentiation of prefrontal cortex	5.20E-03	 	 	 	 	Nrgn	1	
Cell Death and Survival	mitochondrial cell death	Mitochondrial cell death of squamous cell carcinoma cell lines	5.20E-03	 	 	 	 	DDX58	1	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	mobilization	Mobilization of myeloid-derived suppressor cells	5.20E-03	 	 	 	 	STAT1	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	phosphorylation	Phosphorylation of UMP	5.20E-03	 	 	 	 	CMPK2	1	
Drug Metabolism, Nucleic Acid Metabolism, Small Molecule Biochemistry	phosphorylation	Phosphorylation of cytarabine	5.20E-03	 	 	 	 	CMPK2	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	phosphorylation	Phosphorylation of dCMP	5.20E-03	 	 	 	 	CMPK2	1	
Cell Cycle	polyploidy	Polyploidy of bone marrow cell lines	5.20E-03	 	 	 	 	STAT1	1	
Nervous System Development and Function, Tissue Morphology	quantity	Quantity of satellite cells	5.20E-03	 	 	 	 	SDC3	1	
Lymphoid Tissue Structure and Development, Organ Morphology, Tissue Morphology	quantity	Quantity of thymic medullary epithelial cells	5.20E-03	 	 	 	 	STAT1	1	
Cell Cycle	replication	Replication of Rickettsia conorii str. Malish 7	5.20E-03	 	 	 	 	STAT1	1	
Infectious Diseases	replication	Replication of West Nile virus strain (3000.0259)	5.20E-03	 	 	 	 	RSAD2	1	
Protein Synthesis	translation	Translation of green fluorescent protein	5.20E-03	 	 	 	 	EIF2AK2	1	
Cancer, Organismal Injury and Abnormalities	tumorigenesis	Tumorigenesis of endometrial cancer cell lines	5.20E-03	 	 	 	 	STAT1	1	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	psoriasis	Chronic psoriasis	5.29E-03	 	 	 	 	IRF7,STAT1,LGALS3BP	3	
Cell Death and Survival	apoptosis	Apoptosis of lymphocytes	5.73E-03	 	-0.418	 	-0.222	EIF2AK2,DHX58,Irgm1,STAT1,PARP14	5	
Cell Death and Survival	apoptosis	Apoptosis of pancreatic cancer cell lines	5.73E-03	 	 	 	 	STAT1,DDX58,USP18	3	
Cell-To-Cell Signaling and Interaction	activation	Activation of cells	5.82E-03	 	1.023	bias	0.399	EIF2AK2,IRF7,STAT1,DDX58,ZBP1,LGALS3BP,USP18,IFI16,JMJD6	9	
Cardiovascular System Development and Function, Organismal Development	sprouting angiogenesis	Sprouting angiogenesis	6.10E-03	 	 	 	 	RNF213,JMJD6	2	
Cell Death and Survival	apoptosis	Apoptosis of melanoma cell lines	6.31E-03	 	 	 	 	Irgm1,XAF1,STAT2	3	
Cell Death and Survival	cell death	Cell death of bone marrow-derived macrophages	6.37E-03	 	 	 	 	EIF2AK2,STAT1	2	
Infectious Diseases	infection	Infection by Dengue virus 2	6.37E-03	 	 	 	 	RSAD2,STAT1	2	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of phagocytes	6.37E-03	 	 	 	 	EIF2AK2,STAT1	2	
Cell-To-Cell Signaling and Interaction	sensitization	Sensitization of cells	6.37E-03	 	 	 	 	STAT1,PARP14	2	
Cell-To-Cell Signaling and Interaction	signaling	Signaling of cells	6.68E-03	 	 	 	 	STAT1,NLRC5,DDX58	3	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	development	Development of erythroid precursor cells	6.92E-03	 	 	 	 	EIF2AK2,STAT1	2	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of endometrial cancer cell lines	7.79E-03	 	 	 	 	STAT1	1	
Cell Cycle, Cellular Growth and Proliferation	antiproliferative response	Antiproliferative response of fibroblasts	7.79E-03	 	 	 	 	STAT1	1	
Hematological System Development and Function, Lymphoid Tissue Structure and Development, Organ Morphology, Organismal Development, Tissue Morphology	architecture	Architecture of thymus gland	7.79E-03	 	 	 	 	IRF7	1	
Cell Cycle	cell cycle progression	Arrest in cell cycle progression of B lymphoblastoid cell lines	7.79E-03	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation	growth	Arrest in growth of fibrosarcoma cell lines	7.79E-03	 	 	 	 	STAT1	1	
Cellular Compromise, Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development	calcification	Calcification of osteoblasts	7.79E-03	 	 	 	 	EIF2AK2	1	
Cell Death and Survival, Nervous System Development and Function	cell survival	Cell survival of oligodendrocytes	7.79E-03	 	 	 	 	XAF1	1	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	chronic inflammation	Chronic inflammation of joint	7.79E-03	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Humoral Immune Response, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of peripheral B lymphocytes	7.79E-03	 	 	 	 	STAT1	1	
Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	familial hypercholanemia	Familial hypercholanemia	7.79E-03	 	 	 	 	TJP2	1	
Cell Cycle, Skeletal and Muscular System Development and Function	G1/S phase transition	G1/S phase transition of vascular smooth muscle cells	7.79E-03	 	 	 	 	EIF2AK2	1	
Cellular Growth and Proliferation, Organismal Development	growth	Growth of Salmonella enterica	7.79E-03	 	 	 	 	USP18	1	
Infectious Diseases	infection	Infection by Chlamydia trachomatis	7.79E-03	 	 	 	 	Irgm1	1	
Infectious Diseases	infection	Infection by Newcastle disease virus	7.79E-03	 	 	 	 	STAT1	1	
Infectious Diseases	infection	Infection by Sindbis virus	7.79E-03	 	 	 	 	STAT1	1	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of peritoneal macrophages	7.79E-03	 	 	 	 	EIF2AK2	1	
Cell Death and Survival, Organismal Injury and Abnormalities, Renal and Urological Disease	necroptosis	Necroptosis of kidney cell lines	7.79E-03	 	 	 	 	ZBP1	1	
Cellular Assembly and Organization	polarization	Polarization of mitochondrial membrane	7.79E-03	 	 	 	 	Irgm1	1	
Tissue Morphology	quantity	Quantity of Listeria monocytogenes strain EGD	7.79E-03	 	 	 	 	Irgm1	1	
Infectious Diseases	replication	Replication of bovine rotavirus (UK strain)	7.79E-03	 	 	 	 	EIF2AK2	1	
Cell Death and Survival, Cellular Development, Cellular Function and Maintenance	self-renewal	Self-renewal of satellite cells	7.79E-03	 	 	 	 	SDC3	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	stabilization	Stabilization of tight junctions	7.79E-03	 	 	 	 	TJP2	1	
Cell Cycle, Gene Expression	binding	Binding of DNA	7.88E-03	Increased	2.034	 	1.742	IRF9,IRF7,STAT1,DDX58,ZBP1,IFI16	6	
Cell Death and Survival	cell death	Cell death of tumor cell lines	8.03E-03	 	1.416	 	1.683	EIF2AK2,IRF9,Irgm1,XAF1,STAT1,STAT2,HPCA,DDX58,PARP14,LGALS3BP,USP18,IFI16	12	
Cell Death and Survival, Embryonic Development	cell death	Cell death of embryonic cell lines	8.24E-03	 	1.362	 	1.015	EIF2AK2,STAT1,TJP2,ZBP1,IFI16	5	
Infectious Diseases	production	Production of HIV-1	9.00E-03	 	 	 	 	EIF2AK2,RSAD2	2	
Cell Death and Survival	necrosis	Necrosis	9.28E-03	 	1.642	 	2.011	EIF2AK2,IRF9,DHX58,STAT2,TJP2,OAS2,DDX58,USP18,Irgm1,IRF7,XAF1,STAT1,HPCA,PARP14,ZBP1,LGALS3BP,IFI16	17	
Infectious Diseases	infection	Infection by Flaviviridae	9.60E-03	 	 	 	 	RSAD2,STAT1,DDX58	3	
Cell Cycle	interphase	Delay in initiation of interphase	9.64E-03	 	 	 	 	STAT1,IFI16	2	
Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Tissue Development	accumulation	Accumulation of plasmacytoid dendritic cells	1.04E-02	 	 	 	 	STAT1	1	
DNA Replication, Recombination, and Repair, RNA Post-Transcriptional Modification	annealing	Annealing of RNA	1.04E-02	 	 	 	 	EIF2AK2	1	
Embryonic Development, Organismal Development	gastrulation	Arrest in gastrulation	1.04E-02	 	 	 	 	TJP2	1	
Cell-To-Cell Signaling and Interaction	attachment	Attachment of prostate cancer cell lines	1.04E-02	 	 	 	 	SDC3	1	
Cell Cycle, Gene Expression	binding	Binding of GATA-4 binding site	1.04E-02	 	 	 	 	IFI16	1	
Cell Cycle, Gene Expression	binding	Binding of Nkx2.5 binding site	1.04E-02	 	 	 	 	IFI16	1	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	experimental systemic lupus erythematosus	Experimental systemic lupus erythematosus	1.04E-02	 	 	 	 	ZBP1	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	formation	Formation of colony forming unit-megakaryocytes	1.04E-02	 	 	 	 	Ifi27l2a/Ifi27l2b	1	
Cell Cycle	G0 phase	G0 phase of hematopoietic progenitor cells	1.04E-02	 	 	 	 	EIF2AK2	1	
Infectious Diseases	infection	Infection by encephalomyocarditis virus	1.04E-02	 	 	 	 	STAT1	1	
Infectious Diseases	infection	Infection of macrophage cancer cell lines	1.04E-02	 	 	 	 	EIF2AK2	1	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities, Reproductive System Disease, Skeletal and Muscular Disorders	metastasis to bone	Metastasis to bone of breast cancer cell lines	1.04E-02	 	 	 	 	IRF7	1	
Inflammatory Disease	microabscess	Microabscess	1.04E-02	 	 	 	 	STAT1	1	
Cellular Growth and Proliferation	proliferation	Proliferation of Salmonella enterica subsp. enterica serovar Typhimurium	1.04E-02	 	 	 	 	PARP14	1	
Cell Cycle	replication	Replication of Chlamydophila pneumoniae CWL029	1.04E-02	 	 	 	 	IRF7	1	
Infectious Diseases	replication	Replication of Influenza B virus	1.04E-02	 	 	 	 	EIF2AK2	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Inflammatory Response	sensitization	Sensitization of macrophages	1.04E-02	 	 	 	 	STAT1	1	
Tissue Morphology	quantity	Quantity of bacteria	1.10E-02	 	 	 	 	Irgm1,STAT1	2	
Cell-To-Cell Signaling and Interaction	communication	Communication of cells	1.24E-02	 	0.819	 	0.799	IRF9,ADGRG5,STAT1,NLRC5,DDX58,Nrgn,LGALS3BP,JMJD6,SDC3	9	
Post-Translational Modification	autoubiquitination	Autoubiquitination of protein	1.28E-02	 	 	 	 	RNF213,Trim30a/Trim30d	2	
Cellular Movement	migration	Migration of squamous cell carcinoma cell lines	1.28E-02	 	 	 	 	DDX58,IFIT2	2	
Cell Death and Survival, Embryonic Development	apoptosis	Apoptosis of embryonic cell lines	1.29E-02	 	1.029	 	0.657	EIF2AK2,STAT1,TJP2,IFI16	4	
Connective Tissue Disorders, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	rheumatoid arthritis	Chronic phase rheumatoid arthritis	1.29E-02	 	 	 	 	SDC3	1	
Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	contact growth inhibition	Contact growth inhibition of melanoma cell lines	1.29E-02	 	 	 	 	STAT1	1	
Cellular Development, Nervous System Development and Function, Tissue Development	differentiation	Differentiation of striatal neurons	1.29E-02	 	 	 	 	ARPP21	1	
Infectious Diseases	entrance	Entrance of human herpesvirus 1	1.29E-02	 	 	 	 	EIF2AK2	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Hematological System Development and Function, Immune Cell Trafficking, Infectious Diseases, Inflammatory Response	fusion	Fusion of foreign body giant cell	1.29E-02	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	hematopoiesis	Hematopoiesis of myeloid progenitor cells	1.29E-02	 	 	 	 	EIF2AK2	1	
Cell Death and Survival	necroptosis	Necroptosis of cervical cancer cell lines	1.29E-02	 	 	 	 	STAT1	1	
Cell Death and Survival, Organismal Injury and Abnormalities	necroptosis	Necroptosis of epithelial cell lines	1.29E-02	 	 	 	 	ZBP1	1	
Humoral Immune Response, Protein Synthesis	production	Production of anti-DNA antibody	1.29E-02	 	 	 	 	IRF7	1	
Infectious Diseases	release	Release of Influenza A virus	1.29E-02	 	 	 	 	RSAD2	1	
Infectious Diseases	replication	Replication of virus chimera	1.29E-02	 	 	 	 	EIF2AK2	1	
Cell Cycle	G0/G1 phase transition	Arrest in G0/G1 phase transition	1.31E-02	 	 	 	 	EIF2AK2,STAT1	2	
Inflammatory Response, Ophthalmic Disease, Organismal Injury and Abnormalities	inflammation	Inflammation of eye	1.31E-02	 	 	 	 	IRF9,STAT1	2	
Neurological Disease	dystonia	Dystonia	1.39E-02	 	 	 	 	HPCA,SCN4B	2	
Cell-To-Cell Signaling and Interaction, Embryonic Development	response	Response of embryonic cell lines	1.39E-02	 	 	 	 	IRF7,DDX58	2	
Cell Death and Survival	apoptosis	Apoptosis of lymphoma cell lines	1.53E-02	 	 	 	 	EIF2AK2,STAT1,STAT2	3	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	deposition	Deposition of hyaluronic acid	1.55E-02	 	 	 	 	STAT1	1	
Small Molecule Biochemistry	formation	Formation of nitrite	1.55E-02	 	 	 	 	EIF2AK2	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	generation	Generation of CD4+ T-lymphocytes	1.55E-02	 	 	 	 	DDX58	1	
Connective Tissue Development and Function, Embryonic Development, Organ Morphology, Organismal Development, Skeletal and Muscular System Development and Function, Tissue Development	mass	Mass of tibia	1.55E-02	 	 	 	 	STAT1	1	
Cell Morphology, Hematological System Development and Function, Inflammatory Response, Tissue Morphology	morphology	Morphology of bone marrow-derived macrophages	1.55E-02	 	 	 	 	Irgm1	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function	proliferation	Proliferation of satellite cells	1.55E-02	 	 	 	 	SDC3	1	
Antigen Presentation, Protein Synthesis	quantity	Quantity of MHC Class I on cell surface	1.55E-02	 	 	 	 	STAT1	1	
Developmental Disorder, Organismal Survival	sudden infant death syndrome	Sudden infant death syndrome	1.55E-02	 	 	 	 	SCN4B	1	
Infectious Diseases	viremia	Viremia	1.55E-02	 	 	 	 	OASL	1	
Cell Death and Survival	cell death	Cell death of fibroblast cell lines	1.55E-02	 	0.951	 	0.672	EIF2AK2,IRF7,STAT1,USP18,IFI16	5	
Cellular Function and Maintenance, Hematological System Development and Function	function	Function of lymphocytes	1.57E-02	 	 	 	 	IRF7,STAT1,NLRC5,Trim30a/Trim30d	4	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	binding	Binding of macrophages	1.59E-02	 	 	 	 	Irgm1,JMJD6	2	
Cell Death and Survival, Organismal Injury and Abnormalities	cell death	Cell death of epithelial cell lines	1.69E-02	 	1.067	 	0.765	EIF2AK2,OAS2,TJP2,ZBP1	4	
Hematological System Development and Function, Lymphoid Tissue Structure and Development, Tissue Morphology	quantity	Quantity of memory T lymphocytes	1.71E-02	 	 	 	 	STAT1,DDX58	2	
Post-Translational Modification	polyubiquitination	Polyubiquitination	1.76E-02	 	 	 	 	HERC6,RNF213,IFI16	3	
Cell Death and Survival, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	apoptosis	Apoptosis of beta islet cells	1.80E-02	 	 	 	 	STAT1,USP18	2	
Cell-To-Cell Signaling and Interaction	activation	Activation of macrophage cancer cell lines	1.81E-02	 	 	 	 	ZBP1	1	
Gene Expression, RNA Post-Transcriptional Modification	binding	Binding of dsRNA	1.81E-02	 	 	 	 	EIF2AK2	1	
Post-Translational Modification, Protein Folding, Protein Trafficking	conjugation	Conjugation of protein	1.81E-02	 	 	 	 	USP18	1	
Cellular Development	epithelial-mesenchymal transition	Epithelial-mesenchymal transition of squamous cell carcinoma cell lines	1.81E-02	 	 	 	 	IFIT2	1	
Connective Tissue Development and Function, Embryonic Development, Organ Development, Organismal Development, Skeletal and Muscular System Development and Function, Tissue Development	osteoclastogenesis	Osteoclastogenesis of tibia	1.81E-02	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation	proliferation	Proliferation of B lymphoblastoid cell lines	1.81E-02	 	 	 	 	STAT1	1	
Infectious Diseases	replication	Replication of Dengue virus 2	1.81E-02	 	 	 	 	OASL	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function	activation	Activation of myeloid cells	1.84E-02	 	 	 	 	STAT1,LGALS3BP,USP18,JMJD6	4	
Cell Death and Survival	cell death	Cell death of connective tissue cells	1.89E-02	 	1.328	 	1.243	EIF2AK2,IRF7,STAT1,DDX58,USP18,IFI16	6	
Cell Death and Survival	cell death	Cell death of squamous cell carcinoma cell lines	1.93E-02	 	 	 	 	STAT1,DDX58	2	
Cellular Development, Cellular Growth and Proliferation	proliferation	Proliferation of kidney cancer cell lines	1.93E-02	 	 	 	 	SLFN5,LGALS3BP	2	
Cancer, Organismal Injury and Abnormalities	lymphoreticular neoplasm	Lymphoreticular neoplasm	1.98E-02	 	 	 	 	EIF2AK2,RSAD2,OASL,NLRC5,STAT2,RNF213,OAS2,TJP2,DDX58,IFIT2,IRF7,STAT1,ARPP21,IFI35,PARP14	15	
Cell Death and Survival	apoptosis	Apoptosis	2.01E-02	 	1.053	 	1.505	EIF2AK2,DHX58,STAT2,TJP2,DDX58,IFIT2,USP18,Ifi27l2a/Ifi27l2b,Irgm1,IRF7,XAF1,STAT1,HPCA,PARP14,LGALS3BP,IFI16	16	
Cell Death and Survival, Renal and Urological System Development and Function	cell viability	Cell viability of kidney cell lines	2.01E-02	 	 	 	 	IRF9,STAT2	2	
Infectious Diseases	infection	Infection of tumor cell lines	2.05E-02	 	0.625	bias	 	EIF2AK2,STAT1,STAT2,IFI35,DDX58	5	
Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	abnormal morphology	Abnormal morphology of enlarged uterus	2.06E-02	 	 	 	 	DHX58	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of bone marrow-derived macrophages	2.06E-02	 	 	 	 	Irgm1	1	
Cell Death and Survival	apoptosis	Apoptosis of oligodendrocyte precursor cells	2.06E-02	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	development	Development of dendritic precursor cells	2.06E-02	 	 	 	 	STAT1	1	
Infectious Diseases	infection	Infection by Chlamydia pneumoniae	2.06E-02	 	 	 	 	STAT1	1	
Cell Morphology	polarization	Polarization of macrophage cancer cell lines	2.06E-02	 	 	 	 	ZBP1	1	
Infectious Diseases	replication	Replication of Murine cytomegalovirus	2.06E-02	 	 	 	 	STAT1	1	
Infectious Diseases	replication	Replication of Vesicular stomatitis Indiana virus	2.06E-02	 	 	 	 	DDX58	1	
Connective Tissue Disorders, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	immune thrombocytopenia	Immune thrombocytopenia	2.11E-02	 	 	 	 	OAS2,JMJD6	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	nasal type extranodal NK-/T-cell lymphoma	Nasal type extranodal NK-/T-cell lymphoma	2.11E-02	 	 	 	 	STAT1,STAT2	2	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	mature lymphocytic neoplasm	Mature lymphocytic neoplasm	2.28E-02	 	 	 	 	RSAD2,IRF7,STAT1,ARPP21,OASL,STAT2,IFI35,OAS2,DDX58,IFIT2	10	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	encephalitis	Encephalitis	2.29E-02	 	0.084	 	-0.066	IRF9,Irgm1,STAT1,USP18	4	
Organismal Development, Organismal Injury and Abnormalities	shape	Abnormal shape of head	2.32E-02	 	 	 	 	JMJD6	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of Th9 cells	2.32E-02	 	 	 	 	STAT1	1	
Cellular Development, Connective Tissue Development and Function, Tissue Development	differentiation	Differentiation of fibrocytes	2.32E-02	 	 	 	 	LGALS3BP	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	generation	Generation of plasmacytoid dendritic cells	2.32E-02	 	 	 	 	STAT1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Huntington disease	Grade 3 Huntington disease	2.32E-02	 	 	 	 	SCN4B	1	
Infectious Diseases, Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	herpes simplex encephalitis	Herpes simplex encephalitis	2.32E-02	 	 	 	 	STAT1	1	
Inflammatory Disease, Inflammatory Response, Ophthalmic Disease, Organismal Injury and Abnormalities	inflammation	Inflammation of iris	2.32E-02	 	 	 	 	STAT1	1	
Inflammatory Response, Ophthalmic Disease, Organismal Injury and Abnormalities	inflammation	Inflammation of retina	2.32E-02	 	 	 	 	IRF9	1	
Cellular Development, Hematological System Development and Function, Lymphoid Tissue Structure and Development	maturation	Maturation of neutrophils	2.32E-02	 	 	 	 	STAT1	1	
Cell Cycle, Hematological System Development and Function	mitogenesis	Mitogenesis of T lymphocytes	2.32E-02	 	 	 	 	STAT1	1	
Nucleic Acid Metabolism, Small Molecule Biochemistry	phosphorylation	Phosphorylation of nucleoside diphosphates	2.32E-02	 	 	 	 	CMPK2	1	
Protein Synthesis	quantity	Quantity of IFNB1 in blood	2.32E-02	 	 	 	 	DHX58	1	
Cell Cycle	senescence	Senescence of prostate cancer cell lines	2.32E-02	 	 	 	 	IFI16	1	
Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development	volume	Volume of compact bone	2.32E-02	 	 	 	 	STAT1	1	
Cell Death and Survival	apoptosis	Apoptosis of fibroblast cell lines	2.36E-02	 	0.617	 	0.325	EIF2AK2,STAT1,USP18,IFI16	4	
Gene Expression	expression	Expression of RNA	2.38E-02	 	0.964	 	0.417	EIF2AK2,IRF9,DHX58,NLRC5,STAT2,DDX58,JMJD6,HELZ2,IRF7,Mx1,STAT1,PARP14,ZBP1,IFI16	14	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of Th2 cells	2.44E-02	 	 	 	 	RSAD2,STAT1	2	
Hematological Disease, Infectious Diseases, Organismal Injury and Abnormalities	endotoxin shock response	Endotoxin shock response	2.44E-02	 	 	 	 	STAT1,Trim30a/Trim30d	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	differentiation	Differentiation of antigen presenting cells	2.46E-02	 	 	 	 	IRF7,STAT1,USP18	3	
Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders	relapsing-remitting multiple sclerosis	Relapsing-remitting multiple sclerosis	2.53E-02	 	 	 	 	RSAD2,IRF7	2	
Cell Morphology, Hematological System Development and Function, Immunological Disease	abnormal morphology	Abnormal morphology of granulocytes	2.57E-02	 	 	 	 	DDX58	1	
Cellular Assembly and Organization	binding	Binding of ribosome	2.57E-02	 	 	 	 	EIF2AK2	1	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	chronic large plaque psoriasis	Chronic large plaque psoriasis	2.57E-02	 	 	 	 	STAT1	1	
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	chronic small plaque psoriasis	Chronic small plaque psoriasis	2.57E-02	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	development	Development of burst-forming erythroid cells	2.57E-02	 	 	 	 	STAT1	1	
Cellular Development	differentiation	Differentiation of multinucleated cells	2.57E-02	 	 	 	 	USP18	1	
Cellular Function and Maintenance, Hematological System Development and Function	elimination	Elimination of lymphocytes	2.57E-02	 	 	 	 	NLRC5	1	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	femur osteosarcoma	Femur osteosarcoma	2.57E-02	 	 	 	 	PARP14	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	generation	Generation of bone marrow-derived dendritic cells	2.57E-02	 	 	 	 	USP18	1	
Infectious Diseases	infection	Infection by Trypanosoma cruzi	2.57E-02	 	 	 	 	Irgm1	1	
Infectious Diseases	infection	Infection by West Nile virus	2.57E-02	 	 	 	 	DDX58	1	
Cellular Movement	migration	Migration of chronic lymphocytic leukemia cells	2.57E-02	 	 	 	 	STAT1	1	
Cell-To-Cell Signaling and Interaction, Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	recruitment	Recruitment of CD8+ T lymphocyte	2.57E-02	 	 	 	 	DDX58	1	
Infectious Diseases	replication	Replication of respiratory syncytial virus	2.57E-02	 	 	 	 	OASL	1	
Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development, Tissue Morphology	thickness	Thickness of trabecula	2.57E-02	 	 	 	 	STAT1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of phagocytes	2.60E-02	 	 	 	 	STAT1,LGALS3BP,USP18,JMJD6	4	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of CD4+ T-lymphocytes	2.63E-02	 	 	 	 	STAT1,DDX58	2	
Cellular Development, Hematological System Development and Function, Lymphoid Tissue Structure and Development	maturation	Maturation of leukocytes	2.68E-02	 	 	 	 	STAT1,DDX58,PARP14	3	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease	ovarian serous tumor	Ovarian serous tumor	2.72E-02	 	 	 	 	SLFN5,STAT1,STAT2,USP18,JMJD6,LIPM	6	
Gene Expression	activation	Activation of DNA endogenous promoter	2.79E-02	 	1.368	 	0.941	IRF9,IRF7,STAT1,NLRC5,STAT2,DDX58,IFI16,JMJD6,HELZ2	9	
Gene Expression	transcription	Transcription of RNA	2.83E-02	 	1.606	 	1.066	EIF2AK2,IRF9,IRF7,Mx1,STAT1,NLRC5,STAT2,DDX58,ZBP1,IFI16,JMJD6,HELZ2	12	
Cell-To-Cell Signaling and Interaction	activation	Activation of lymphoma cell lines	2.83E-02	 	 	 	 	EIF2AK2	1	
Cell Death and Survival	cell death	Cell death of hair cells	2.83E-02	 	 	 	 	STAT1	1	
Cell Cycle, Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	contact growth inhibition	Contact growth inhibition of carcinoma cell lines	2.83E-02	 	 	 	 	IFI16	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Hematological System Development and Function, Immune Cell Trafficking, Infectious Diseases, Inflammatory Response	fusion	Fusion of bone marrow-derived macrophages	2.83E-02	 	 	 	 	STAT1	1	
Cell-To-Cell Signaling and Interaction, Inflammatory Response	immune response	Immune response of epithelial cells	2.83E-02	 	 	 	 	DDX58	1	
Cell Signaling, Small Molecule Biochemistry	induction	Induction of nitric oxide	2.83E-02	 	 	 	 	STAT1	1	
Cellular Movement	migration	Migration of endometrial cancer cell lines	2.83E-02	 	 	 	 	STAT1	1	
Cell-To-Cell Signaling and Interaction, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Nervous System Development and Function	recruitment	Recruitment of microglia	2.83E-02	 	 	 	 	IRF7	1	
Cancer, Dermatological Diseases and Conditions, Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	tuberous sclerosis complex	Tuberous sclerosis complex	2.83E-02	 	 	 	 	PARP14	1	
Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of organ	2.87E-02	 	-0.799	 	-0.363	PARP12,EIF2AK2,IRF9,IRF7,Irgm1,Mx1,STAT1,DDX58,USP18	9	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	thrombocytopenia	Thrombocytopenia	3.02E-02	 	 	 	 	IRF7,OAS2,JMJD6	3	
Cell Death and Survival, Organismal Injury and Abnormalities	cell death	Cell death of epithelial cells	3.03E-02	 	1.387	 	1.307	EIF2AK2,STAT1,OAS2,TJP2,ZBP1	5	
Cell-To-Cell Signaling and Interaction	activation	Activation of tumor cell lines	3.05E-02	 	 	 	 	EIF2AK2,ZBP1	2	
Cell Death and Survival	apoptosis	Apoptosis of B lymphoblastoid cell lines	3.08E-02	 	 	 	 	STAT1	1	
Cardiovascular Disease, Hereditary Disorder, Organismal Injury and Abnormalities	catecholaminergic polymorphic ventricular tachycardia type 1	Catecholaminergic polymorphic ventricular tachycardia type 1	3.08E-02	 	 	 	 	SCN4B	1	
Infectious Diseases	infection	Infection by Salmonella enterica subsp. enterica serovar Typhimurium	3.08E-02	 	 	 	 	USP18	1	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	influx	Influx of macrophages	3.08E-02	 	 	 	 	IRF7	1	
Cardiovascular System Development and Function, Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Organ Development, Tissue Development	proliferation	Proliferation of cardiac fibroblasts	3.08E-02	 	 	 	 	STAT1	1	
Infectious Diseases	replication	Replication of encephalomyocarditis virus	3.08E-02	 	 	 	 	DDX58	1	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities, Reproductive System Disease	serous adenocarcinoma	Serous adenocarcinoma in ovary	3.11E-02	 	 	 	 	SLFN5,STAT2,USP18,JMJD6,LIPM	5	
Inflammatory Response	inflammation	Inflammation of absolute anatomical region	3.15E-02	 	-0.615	 	-0.197	PARP12,IRF9,IRF7,Irgm1,Mx1,STAT1,DDX58,USP18	8	
Cell Cycle	cell cycle progression	Cell cycle progression	3.17E-02	 	1.757	 	1.379	EIF2AK2,IRF9,IRF7,Irgm1,STAT1,DDX58,IFI16,SDC3	8	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of macrophages	3.20E-02	 	 	 	 	STAT1,USP18,JMJD6	3	
Cell Death and Survival, Hair and Skin Development and Function	cell viability	Cell viability of epithelial cell lines	3.21E-02	 	 	 	 	IRF9,STAT2	2	
Immunological Disease	immunodeficiency	Immunodeficiency	3.26E-02	 	 	 	 	IRF7,STAT1,STAT2	3	
Digestive System Development and Function, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of intestine	3.29E-02	 	 	 	 	STAT1,DDX58,JMJD6	3	
Cellular Assembly and Organization, Cellular Function and Maintenance	fluidity	Fluidity of cellular membrane	3.33E-02	 	 	 	 	RSAD2	1	
Nervous System Development and Function, Tissue Morphology	quantity	Quantity of GABAergic neurons	3.33E-02	 	 	 	 	SDC3	1	
Gene Expression	replication	Replication of RNA	3.33E-02	 	 	 	 	USP18	1	
Hematological System Development and Function, Tissue Morphology	morphology	Morphology of bone marrow	3.38E-02	 	 	 	 	Irgm1,STAT1	2	
Cellular Function and Maintenance	function	Function of dendritic cells	3.43E-02	 	 	 	 	STAT2,DDX58	2	
Gene Expression	transcription	Transcription	3.45E-02	 	1.333	 	0.725	EIF2AK2,IRF9,NLRC5,STAT2,DDX58,JMJD6,HELZ2,IRF7,Mx1,STAT1,PARP14,ZBP1,IFI16	13	
Cell Death and Survival	apoptosis	Apoptosis of macrophages	3.49E-02	 	 	 	 	EIF2AK2,STAT1	2	
Infectious Diseases	anthrax	Anthrax	3.58E-02	 	 	 	 	STAT1	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Skeletal and Muscular System Development and Function, Tissue Development	osteoclastogenesis	Osteoclastogenesis of bone-marrow-derived monocyte/macrophage precursor cells	3.58E-02	 	 	 	 	STAT1	1	
Neurological Disease, Organismal Injury and Abnormalities	vertigo	Vertigo	3.58E-02	 	 	 	 	USP18	1	
Cellular Development, Hematological System Development and Function, Lymphoid Tissue Structure and Development	maturation	Maturation of dendritic cells	3.66E-02	 	 	 	 	STAT1,DDX58	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	monocytopoiesis	Monocytopoiesis	3.72E-02	 	 	 	 	IRF7,IFI16	2	
Cellular Function and Maintenance	function	Function of antigen presenting cells	3.77E-02	 	 	 	 	STAT1,STAT2,DDX58	3	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	hematopoiesis	Hematopoiesis of erythroid precursor cells	3.84E-02	 	 	 	 	EIF2AK2	1	
Infectious Diseases	infection	Infection by adenoviridae	3.84E-02	 	 	 	 	EIF2AK2	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development	osteoclastogenesis	Osteoclastogenesis of osteoclast precursor cells	3.84E-02	 	 	 	 	STAT1	1	
Infectious Diseases	replication	Replication of Sendai virus	3.84E-02	 	 	 	 	OASL	1	
Cancer, Connective Tissue Disorders, Organismal Injury and Abnormalities	connective tissue cancer	Connective tissue cancer	3.94E-02	 	 	 	 	IRF7,PARP14,LGALS3BP	3	
Cell Death and Survival	necroptosis	Necroptosis	3.95E-02	 	 	 	 	STAT1,ZBP1	2	
Inflammatory Response	immune response	Immune response of cells	4.01E-02	Increased	2.177	bias	1.483	EIF2AK2,DHX58,IRF7,STAT1,DDX58	5	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance, Inflammatory Response	accumulation	Accumulation of autophagosomes	4.09E-02	 	 	 	 	EIF2AK2	1	
Antimicrobial Response, Inflammatory Response	antiviral response	Antiviral response of fibroblast cell lines	4.09E-02	 	 	 	 	DDX58	1	
Cellular Development, Cellular Growth and Proliferation	proliferation	Arrest in proliferation of lymphoma cell lines	4.09E-02	 	 	 	 	STAT1	1	
Neurological Disease	myoclonic dystonia	Myoclonic dystonia	4.09E-02	 	 	 	 	SCN4B	1	
Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	nonfamilial Alzheimer disease	Nonfamilial Alzheimer disease	4.09E-02	 	 	 	 	EIF2AK2	1	
Infectious Diseases	quantity	Quantity of Influenza A virus	4.09E-02	 	 	 	 	Mx1	1	
Cellular Assembly and Organization	rearrangement	Rearrangement of actin filaments	4.09E-02	 	 	 	 	IFI16	1	
Cellular Development, Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development	differentiation	Differentiation of osteoblasts	4.25E-02	 	 	 	 	EIF2AK2,STAT1,IFI16	3	
Infectious Diseases	infection	Infection of cells	4.29E-02	 	-0.845	bias	 	EIF2AK2,RSAD2,STAT1,STAT2,IFI35,DDX58	6	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of bone marrow-derived macrophages	4.34E-02	 	 	 	 	USP18	1	
Cell-To-Cell Signaling and Interaction, Skeletal and Muscular System Development and Function	adhesion	Adhesion of smooth muscle cells	4.34E-02	 	 	 	 	STAT1	1	
Cell Cycle	cell cycle progression	Arrest in cell cycle progression of lymphoma cell lines	4.34E-02	 	 	 	 	STAT1	1	
Cardiovascular Disease, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	familial atrial fibrillation	Familial atrial fibrillation	4.34E-02	 	 	 	 	SCN4B	1	
Hematological System Development and Function, Lymphoid Tissue Structure and Development, Tissue Morphology	quantity	Quantity of effector memory T lymphocytes	4.34E-02	 	 	 	 	STAT1	1	
Cell Signaling, Molecular Transport, Small Molecule Biochemistry	secretion	Secretion of nitric oxide	4.34E-02	 	 	 	 	STAT1	1	
Cell Death and Survival, Embryonic Development	cell viability	Cell viability of embryonic cell lines	4.37E-02	 	 	 	 	IRF9,STAT2	2	
Infectious Diseases	replication	Replication of HIV-1	4.44E-02	 	 	 	 	EIF2AK2,IRF7	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Tissue Development	differentiation	Differentiation of myeloid leukocytes	4.47E-02	 	 	 	 	IRF7,USP18,IFI16	3	
Cellular Function and Maintenance, Hematological System Development and Function	function	Function of T lymphocytes	4.58E-02	 	 	 	 	IRF7,NLRC5,Trim30a/Trim30d	3	
Antimicrobial Response, Cell-To-Cell Signaling and Interaction, Embryonic Development, Inflammatory Response	antiviral response	Antiviral response of embryonic cell lines	4.59E-02	 	 	 	 	DDX58	1	
Cell Death and Survival	apoptosis	Apoptosis of lymphoblasts	4.59E-02	 	 	 	 	EIF2AK2	1	
Cell Death and Survival	apoptosis	Apoptosis of microglia	4.59E-02	 	 	 	 	STAT1	1	
Gastrointestinal Disease, Organismal Injury and Abnormalities	damage	Damage of colon	4.59E-02	 	 	 	 	STAT1	1	
Cell Death and Survival, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	focal necrosis	Focal necrosis of liver	4.59E-02	 	 	 	 	STAT1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Skeletal and Muscular System Development and Function	fusion	Fusion of myotube	4.59E-02	 	 	 	 	IFI16	1	
Immunological Disease	delayed hypersensitive reaction	Delayed hypersensitive reaction	4.62E-02	 	 	 	 	EIF2AK2,LGALS3BP	2	
Cell Death and Survival	apoptosis	Apoptosis of neuroblastoma cell lines	4.69E-02	 	 	 	 	EIF2AK2,HPCA	2	
Cell Death and Survival	cell death	Cell death of neuroglia	4.75E-02	 	 	 	 	STAT1,SDC3	2	
Hereditary Disorder, Immunological Disease, Organismal Injury and Abnormalities	autosomal recessive immunodeficiency	Autosomal recessive immunodeficiency	4.81E-02	 	 	 	 	IRF7,STAT2	2	
Connective Tissue Development and Function, Tissue Development	accumulation	Accumulation of adipose tissue	4.83E-02	 	 	 	 	SDC3	1	
Cell Death and Survival	apoptosis	Apoptosis of bone marrow-derived macrophages	4.83E-02	 	 	 	 	EIF2AK2	1	
Cell Cycle	cell cycle progression	Arrest in cell cycle progression of carcinoma cell lines	4.83E-02	 	 	 	 	IFI16	1	
Cellular Growth and Proliferation	colony formation	Colony formation of melanoma cell lines	4.83E-02	 	 	 	 	SLFN5	1	
Cell Cycle	G1/S phase transition	Delay in initiation of G1/S phase transition	4.83E-02	 	 	 	 	IFI16	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast cancer	TNM stage II breast cancer	4.83E-02	 	 	 	 	CMPK2	1	
Infectious Diseases	toxoplasmosis	Toxoplasmosis	4.83E-02	 	 	 	 	Irgm1	1	
Developmental Disorder, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	vaginal atresia	Vaginal atresia	4.83E-02	 	 	 	 	DHX58	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long term synaptic depression	Long term synaptic depression	4.88E-02	 	 	 	 	SCN4B,Nrgn	2	
Cellular Function and Maintenance	function	Function of phagocytes	4.99E-02	 	 	 	 	STAT1,STAT2,DDX58	3	

Tox Functions for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Cardiac Arrythmia, Congenital Heart Anomaly	long-QT syndrome 10	Long-QT syndrome 10	2.60E-03	 	 	 	 	SCN4B	1	
Liver Cholestasis	progressive familial intrahepatic cholestasis type 4	Progressive familial intrahepatic cholestasis type 4	2.60E-03	 	 	 	 	TJP2	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	systemic lupus erythematosus nephritis	Systemic lupus erythematosus nephritis	3.32E-03	 	 	 	 	PARP12,IRF7	2	
Renal Necrosis/Cell Death	necroptosis	Necroptosis of kidney cell lines	7.79E-03	 	 	 	 	ZBP1	1	
Renal Necrosis/Cell Death	cell viability	Cell viability of kidney cell lines	2.01E-02	 	 	 	 	IRF9,STAT2	2	
Cardiac Arrythmia, Tachycardia	catecholaminergic polymorphic ventricular tachycardia type 1	Catecholaminergic polymorphic ventricular tachycardia type 1	3.08E-02	 	 	 	 	SCN4B	1	
Cardiac Proliferation	proliferation	Proliferation of cardiac fibroblasts	3.08E-02	 	 	 	 	STAT1	1	
Cardiac Arrythmia	familial atrial fibrillation	Familial atrial fibrillation	4.34E-02	 	 	 	 	SCN4B	1	
Liver Necrosis/Cell Death	focal necrosis	Focal necrosis of liver	4.59E-02	 	 	 	 	STAT1	1	
Congenital Heart Anomaly	familial congenital heart disease	Familial congenital heart disease	6.08E-02	 	 	 	 	SCN4B,JMJD6	2	
Renal Necrosis/Cell Death	cell death	Cell death of kidney cell lines	7.96E-02	 	 	 	 	EIF2AK2,TJP2,ZBP1	3	
Degeneration of liver	degeneration	Degeneration of liver	8.49E-02	 	 	 	 	DDX58	1	
Congenital Heart Anomaly	double outlet right ventricle	Double outlet right ventricle	1.25E-01	 	 	 	 	JMJD6	1	
Liver Fibrosis	activation	Activation of hepatic stellate cells	1.27E-01	 	 	 	 	STAT1	1	
Liver Fibrosis, Liver Proliferation	proliferation	Proliferation of hepatic stellate cells	1.31E-01	 	 	 	 	STAT1	1	
Increased Levels of Alkaline Phosphatase	activation	Increased activation of alkaline phosphatase	1.65E-01	 	 	 	 	IFI16	1	
Renal Necrosis/Cell Death	apoptosis	Apoptosis of kidney cell lines	1.74E-01	 	 	 	 	EIF2AK2,TJP2	2	
Liver Enlargement	hepatomegaly	Hepatomegaly	2.22E-01	 	 	 	 	STAT1	1	
Liver Inflammation/Hepatitis	infection	Infection by Hepatitis C virus	2.42E-01	 	 	 	 	DDX58	1	
Cardiac Dilation, Cardiac Enlargement	primary dilated cardiomyopthy	Primary dilated cardiomyopthy	2.44E-01	 	 	 	 	SCN4B	1	
Liver Inflammation/Hepatitis	inflammation	Inflammation of liver	2.73E-01	 	 	 	 	STAT1,DDX58	2	
Liver Damage	hepatic injury	Hepatic injury	3.18E-01	 	 	 	 	STAT1	1	
Liver Necrosis/Cell Death	apoptosis	Apoptosis of hepatocytes	3.41E-01	 	 	 	 	STAT1	1	
Liver Fibrosis	fibrosis	Fibrosis of liver	3.42E-01	 	 	 	 	STAT1	1	
Cardiac Necrosis/Cell Death	cell death	Cell death of cardiomyocytes	4.76E-01	 	 	 	 	STAT1	1	
Liver Steatosis	hepatic steatosis	Hepatic steatosis	6.34E-01	 	 	 	 	HELZ2	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Hepatocellular carcinoma	1.00E00	 	 	 	 	EIF2AK2,RNF213	2	
Liver Hyperplasia/Hyperproliferation	liver carcinoma	Liver carcinoma	1.00E00	 	 	 	 	EIF2AK2,STAT1,OASL,STAT2,RNF213,DDX58,PARP14,ZBP1,IFI16	9	
Liver Hyperplasia/Hyperproliferation	liver tumor	Liver tumor	1.00E00	 	 	 	 	EIF2AK2,STAT1,OASL,STAT2,NLRC5,RNF213,DDX58,PARP14,ZBP1,IFI16	10	

Regulator Effects for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Consistency Score	Node Total	Regulator Total	Regulators	Target Total	Target Molecules in Dataset	Disease & Function Total	Diseases & Functions	Known Regulator-Disease/Function Relationships
136.273	65	39	ACKR2,CGAS,EIF2AK2,FADD,FZD9,Ifn,IFN alpha/beta,IFN Beta,IFN type 1,IFNA2,Ifnar,IFNAR1,IFNL3,IL10RA,IL1RN,IL21,Interferon alpha,IRF1,IRF3,IRF5,Irgm1,JAK,MAPK1,MAVS,NFATC2,NKX2-3,SAMSN1,SASH1,SOCS1,STAT4,TICAM1,TLR3,TLR4,TLR7,TMEM173,TNF,TNFSF10,TNK1,TREX1	19	DDX58,DHX58,IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,IRF7,IRF9,Mx1,NLRC5,OAS2,OASL,Oasl2,PARP12,RSAD2,RTP4,STAT1,STAT2,ZBP1	7	Antiviral response,Binding of DNA,Cytostasis,Immune response of cells,Replication of Influenza A virus,Replication of vesicular stomatitis virus,Replication of viral replicon	37% (100/273)	
82.360	62	35	ACKR2,DDX58,EIF2AK2,FADD,Ifn,IFN Beta,IFNA1/IFNA13,IFNA2,Ifnar,IFNAR1,IFNB1,IFNL3,IFNL4,IL10RA,IL21,Interferon alpha,IRF1,IRF3,IRF5,Irgm1,JAK,JAK1,MAPK1,MAVS,NKX2-3,PRL,SOCS1,STAT4,TICAM1,TLR4,TLR7,TLR9,TNF,TNFSF10,TNK1	19	DHX58,IFI16,Ifi27l2a/Ifi27l2b,IFIT1B,IFIT2,IRF7,IRF9,Mx1,NLRC5,OAS2,OASL,Oasl2,PARP12,RSAD2,RTP4,STAT1,STAT2,USP18,ZBP1	8	Antiviral response,Binding of DNA,Cytostasis,Immune response of cells,Infection of mammalia,Replication of Influenza A virus,Replication of vesicular stomatitis virus,Replication of viral replicon	46% (128/280)	
-3.182	10	1	IFNL1	8	DDX58,EIF2AK2,IFIT2,IRF9,OASL,STAT1,STAT2,USP18	1	Infection of mammalia	0% (0/1)	
-4.919	7	1	STAT3	5	EIF2AK2,IFI16,Mx1,OASL,RSAD2	1	Replication of viral replicon	0% (0/1)	
-4.919	7	1	PNPT1	5	DDX58,EIF2AK2,IFI16,Irgm1,STAT1	1	Cytostasis	0% (0/1)	
-4.919	7	1	IL4	5	IFI16,IRF7,IRF9,STAT1,ZBP1	1	Binding of DNA	100% (1/1)	
-7.273	12	1	IFNG	10	DDX58,EIF2AK2,IFIT2,IRF7,IRF9,Irgm1,OASL,STAT1,STAT2,USP18	1	Infection of mammalia	100% (1/1)	
-7.273	12	1	TRIM24	10	DDX58,DHX58,IFIT2,IRF7,IRF9,Irgm1,OASL,STAT1,STAT2,USP18	1	Infection of mammalia	0% (0/1)	
-7.506	5	1	NRAS	3	IFI16,Irgm1,STAT1	1	Cytostasis	100% (1/1)	
-7.506	5	1	ELAVL1	3	IFI16,Irgm1,STAT1	1	Cytostasis	0% (0/1)	
-14.000	6	1	BTK	4	IFI35,IRF9,OAS2,STAT1	1	Viral Infection	0% (0/1)	
Networks for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
ID	Analysis	Molecules in Network	Score	Focus Molecules	Top Diseases and Functions	
1	R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	Akt,DDX58,DHX58,IFI35,IFIT1B,IFIT2,IFN Beta,IFN alpha/beta,IFN type 1,IRF,IRF7,IRF9,ISGF3,Ifi27l2a/Ifi27l2b,Ifn,Ifnar,Interferon-α Induced,Irgm1,Isg,Mx1,NLRC5,OAS2,OASL,Oasl2,PARP14,RSAD2,RTP4,STAT-1/2,STAT2,Sp100,Stat1-Stat2,TJP2,USP18,XAF1,ZBP1	60	23	Antimicrobial Response, Inflammatory Response, Immunological Disease	
2	R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	ARPP21,CD3,CMPK2,CTXN1,EIF2AK2,HELZ2,HERC6,HPCA,Histone h4,IFI16,IL12 (complex),IL12 (family),Ifn gamma,Ige,Immunoglobulin,Interferon alpha,JAK,JAK1/2,JMJD6,LGALS3BP,MHC CLASS I (family),MHC Class II (complex),Mek,NFkB (complex),Nrgn,PARP12,RNF213,SDC3,SLFN5,STAT,STAT1,TCR,Trim30a/Trim30d,caspase,cytokine	40	17	Immunological Disease, Infectious Diseases, Connective Tissue Disorders	
3	R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	26s Proteasome,ACKR1,ADGRG5,APOBEC3G,C2CD2L,CCL8,CFLAR,CMKLR1,DIO3,ERK,F2,GJD2,HTT,Histone h3,IRF7,Ifi47,Insulin,KL,LDL,MKK3/6,MKNK2,NUS1,P38 MAPK,PARP,PITX1,PTPN1,PTPN22,Pro-inflammatory Cytokine,RAS,RNA polymerase II,SAA,SARM1,SCN4B,SRC (family),TLR10	7	4	Cell Signaling, Molecular Transport, Vitamin and Mineral Metabolism	
4	R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM	CNOT8,LIPM,MALAT1,lipase	2	1	Cancer, Cellular Development, Organismal Injury and Abnormalities	

My Lists for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
My Lists	 -log(p-value)	Ratio	Molecules 

Tox Lists for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
Ingenuity Toxicity Lists	 -log(p-value)	Ratio	Molecules 
Renal Necrosis/Cell Death	1.91E00	9.29E-03	EIF2AK2,IRF9,STAT2,TJP2,ZBP1
Increases Depolarization of Mitochondria and Mitochondrial Membrane	1.36E00	5.88E-02	EIF2AK2
Increases Cardiac Proliferation	9.29E-01	2.08E-02	STAT1
Increases Liver Hepatitis	7.45E-01	1.32E-02	DDX58
Increases Liver Damage	6.87E-01	1.14E-02	STAT1
TGF-β Signaling	6.54E-01	1.04E-02	IRF7
Hepatic Cholestasis	4.38E-01	5.78E-03	TJP2
NF-κB Signaling	4.25E-01	5.56E-03	EIF2AK2
PPARα/RXRα Activation	4.25E-01	5.56E-03	HELZ2
Liver Proliferation	3.25E-01	4.1E-03	STAT1
Cardiac Necrosis/Cell Death	2.9E-01	3.65E-03	STAT1
Liver Necrosis/Cell Death	2.55E-01	3.24E-03	STAT1

My Pathways for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
My Pathways	 -log(p-value)	Ratio	Molecules 

Analysis Ready Molecules for My Projects->hdMouse_Microarray_Final->R62_6wk_Cd11b_Multiprobe - 2019-10-21 09:57 AM
ID	Symbol	Expr Log Ratio	Expr p-value
1436230_at	ADGRG5	0.852203870057549	7.27527471812503E-4
1451280_at	ARPP21	-1.79781784188123	0.00478723340794794
1428095_a_at	C2CD2L	-0.583145007411506	0.0484014636684443
1450484_a_at	CMPK2	1.27606922166556	0.0132901741291762
1435083_at	CTXN1	-1.45714543029256	0.0187033203225233
1456890_at	DDX58	0.601882946239266	7.29423021685707E-5
1451426_at	DHX58	1.10521680451235	8.18467053576966E-4
1440866_at	EIF2AK2	1.02121678911488	1.80282940499169E-4
1435454_a_at	HELZ2	1.41266663305698	7.05364551549426E-4
1438037_at	HERC6	0.604845036182029	0.0274812170279105
1450930_at	HPCA	-1.56288685034589	0.0220579264329172
1437636_at	IFI16	2.3634379844613	3.95707937336733E-5
1426278_at	Ifi27l2a/Ifi27l2b	2.04318510675958	5.59546329962145E-8
1445897_s_at	IFI35	0.372181116140549	0.0159558268930527
1450783_at	IFIT1B	2.24102383007735	3.28517695036388E-8
1418293_at	IFIT2	2.2661071042646	8.37330932948854E-11
1417244_a_at	IRF7	1.81216365544493	1.7150618912839E-9
1421322_a_at	IRF9	0.754091681474648	6.15873619181756E-6
1418825_at	Irgm1	0.599797115826103	7.05364551549426E-4
1454109_a_at	JMJD6	-0.592514692349079	0.0342307505579981
1448380_at	LGALS3BP	0.980111204221195	0.00272116245983434
1430551_s_at	LIPM	0.497580647010012	0.0170244328870329
1451905_a_at	Mx1	1.62412735405158	4.72158454287407E-5
1437176_at	NLRC5	1.4834290419976	7.05364551549426E-4
1423231_at	Nrgn	-1.44387636113791	0.0357068849019746
1425065_at	OAS2	1.82587551421319	8.55017098492253E-6
1424339_at	OASL	1.22645944347553	0.0117213215437472
1453196_a_at	Oasl2	2.420420823296	6.12763852614283E-8
1426774_at	PARP12	0.480474319474594	8.8693910452084E-4
1451564_at	PARP14	0.455366172837826	0.00444200783291191
1455500_at	RNF213	0.554222252825328	8.97079086654722E-4
1421009_at	RSAD2	1.78559486597195	4.40108543608865E-4
1418580_at	RTP4	2.26615972309761	5.61369943752768E-12
1434008_at	SCN4B	-1.43596085240628	0.0360728777208836
1450027_at	SDC3	0.776035898417761	0.0481874616626986
1456288_at	SLFN5	1.70095935823063	1.61240743355909E-5
1451821_a_at	Sp100	0.884221627998555	0.00159333135987726
1450034_at	STAT1	0.706264665587899	7.36816868493969E-5
1421911_at	STAT2	0.576690298342253	0.00397114736442125
1434600_at	TJP2	-0.830721456663086	0.0342307505579981
1451860_a_at	Trim30a/Trim30d	0.468339072895544	0.0015261321548139
1418191_at	USP18	2.2550172003106	5.61369943752768E-12
1443698_at	XAF1	1.28350395545665	1.22393458011374E-7
1429947_a_at	ZBP1	1.57510634879316	0.00177547371755921

